CEO.CA SEDI filings for

SEDI Insider filing browser

Date	Issuer	Insider	Transaction	Amount	New Balance ⓘ The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Recent filings
Filed 2025-07-11 17:30 Tx date 2025-07-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-733,554.0426 -82,382 vol $8.90 each	0
Filed 2025-07-11 17:30 Tx date 2025-07-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$733,554 +82,382 vol $8.90 each	82,382
Filed 2025-07-11 17:29 Tx date 2025-07-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-732,397.491 -82,158 vol $8.91 each	0
Filed 2025-07-11 17:29 Tx date 2025-07-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$732,397 +82,158 vol $8.91 each	82,158
Filed 2025-07-11 17:28 Tx date 2025-07-09	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-651,602.676 -82,520 vol $7.90 each	0
Filed 2025-07-11 17:28 Tx date 2025-07-09	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$651,602 +82,520 vol $7.90 each	82,520
Filed 2025-07-11 17:27 Tx date 2025-07-08	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,248,530.7978 -164,538 vol $7.59 each	0
Filed 2025-07-11 17:27 Tx date 2025-07-08	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,248,530 +164,538 vol $7.59 each	164,538
Filed 2025-07-11 17:27 Tx date 2025-07-07	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,222,589.4375 -163,875 vol $7.46 each	0
Filed 2025-07-11 17:26 Tx date 2025-07-07	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,222,589 +163,875 vol $7.46 each	163,875
Older filings
Filed 2025-07-03 16:10 Tx date 2025-07-03	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,024,275.6058 -136,082 vol $7.53 each	0
Filed 2025-07-03 16:09 Tx date 2025-07-03	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,024,275 +136,082 vol $7.53 each	136,082
Filed 2025-07-03 16:09 Tx date 2025-07-02	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,013,904.5132 -136,772 vol $7.41 each	0
Filed 2025-07-03 16:08 Tx date 2025-07-02	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,013,904 +136,772 vol $7.41 each	136,772
Filed 2025-07-03 16:08 Tx date 2025-07-01	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,064,414.4128 -136,772 vol $7.78 each	0
Filed 2025-07-03 16:07 Tx date 2025-07-01	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,064,414 +136,772 vol $7.78 each	136,772
Filed 2025-07-03 16:07 Tx date 2025-06-30	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-591,764.5738 -68,386 vol $8.65 each	0
Filed 2025-07-03 16:07 Tx date 2025-06-30	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$591,764 +68,386 vol $8.65 each	68,386
Filed 2025-06-27 18:45 Tx date 2025-06-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-442,043.694 -51,330 vol $8.61 each	0
Filed 2025-06-27 18:44 Tx date 2025-06-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$442,043 +51,330 vol $8.61 each	51,330
Filed 2025-06-27 18:44 Tx date 2025-06-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-431,382.3915 -50,145 vol $8.60 each	0
Filed 2025-06-27 18:43 Tx date 2025-06-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$431,382 +50,145 vol $8.60 each	50,145
Filed 2025-06-27 18:43 Tx date 2025-06-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-418,523.2662 -51,834 vol $8.07 each	0
Filed 2025-06-27 18:42 Tx date 2025-06-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$418,523 +51,834 vol $8.07 each	51,834
Filed 2025-06-27 18:41 Tx date 2025-06-24	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-415,475.427 -51,834 vol $8.02 each	0
Filed 2025-06-27 18:40 Tx date 2025-06-24	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$415,475 +51,834 vol $8.02 each	51,834
Filed 2025-06-27 18:39 Tx date 2025-06-23	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-810,196.5204 -103,668 vol $7.82 each	0
Filed 2025-06-27 18:39 Tx date 2025-06-23	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$810,196 +103,668 vol $7.82 each	103,668
Filed 2025-06-20 17:25 Tx date 2025-06-20	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-887,862.08 -113,792 vol $7.80 each	0
Filed 2025-06-20 17:24 Tx date 2025-06-20	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$887,862 +113,792 vol $7.80 each	113,792
Filed 2025-06-20 17:23 Tx date 2025-06-18	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-905,579.4944 -113,792 vol $7.96 each	0
Filed 2025-06-20 17:23 Tx date 2025-06-18	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$905,579 +113,792 vol $7.96 each	113,792
Filed 2025-06-20 17:22 Tx date 2025-06-17	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-885,987.63 -110,790 vol $8.00 each	0
Filed 2025-06-20 17:20 Tx date 2025-06-17	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$885,987 +110,790 vol $8.00 each	110,790
Filed 2025-06-20 17:19 Tx date 2025-06-16	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-467,064.9536 -56,896 vol $8.21 each	0
Filed 2025-06-20 17:18 Tx date 2025-06-16	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$467,064 +56,896 vol $8.21 each	56,896
Filed 2025-06-13 18:57 Tx date 2025-06-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-568,074.9216 -69,658 vol $8.16 each	0
Filed 2025-06-13 18:57 Tx date 2025-06-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$568,074 +69,658 vol $8.16 each	69,658
Filed 2025-06-13 18:57 Tx date 2025-06-12	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-569,878.6628 -69,271 vol $8.23 each	0
Filed 2025-06-13 18:56 Tx date 2025-06-12	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$569,878 +69,271 vol $8.23 each	69,271
Filed 2025-06-13 18:56 Tx date 2025-06-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-564,514.2964 -68,966 vol $8.19 each	0
Filed 2025-06-13 18:55 Tx date 2025-06-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$564,514 +68,966 vol $8.19 each	68,966
Filed 2025-06-13 18:55 Tx date 2025-06-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-560,834.526 -68,654 vol $8.17 each	0
Filed 2025-06-13 18:55 Tx date 2025-06-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$563,285 +68,654 vol $8.20 each	68,654
Filed 2025-06-13 18:54 Tx date 2025-06-09	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-569,036.202 -69,658 vol $8.17 each	0
Filed 2025-06-13 18:54 Tx date 2025-06-09	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$569,036 +69,658 vol $8.17 each	69,658
Filed 2025-06-06 18:44 Tx date 2025-06-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-572,108.9472 -69,783 vol $8.20 each	0
Filed 2025-06-06 18:44 Tx date 2025-06-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$572,108 +69,783 vol $8.20 each	69,783
Filed 2025-06-06 18:43 Tx date 2025-06-05	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-562,813.8516 -69,783 vol $8.07 each	0
Filed 2025-06-06 18:43 Tx date 2025-06-05	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$562,813 +69,783 vol $8.07 each	69,783
Filed 2025-06-06 18:43 Tx date 2025-06-04	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-559,115.3526 -69,783 vol $8.01 each	0
Filed 2025-06-06 18:42 Tx date 2025-06-04	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$559,115 +69,783 vol $8.01 each	69,783
Filed 2025-06-06 18:41 Tx date 2025-06-03	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-565,294.4052 -70,926 vol $7.97 each	0
Filed 2025-06-06 18:41 Tx date 2025-06-03	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$565,294 +70,926 vol $7.97 each	70,926
Filed 2025-06-06 18:41 Tx date 2025-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,105,612.0516 -139,564 vol $7.92 each	0
Filed 2025-06-06 18:40 Tx date 2025-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,105,612 +139,564 vol $7.92 each	139,564
Filed 2025-05-30 17:29 Tx date 2025-05-30	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,009,214.9136 -128,208 vol $7.87 each	0
Filed 2025-05-30 17:28 Tx date 2025-05-30	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,009,214 +128,208 vol $7.87 each	128,208
Filed 2025-05-30 17:27 Tx date 2025-05-29	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-529,651.1724 -66,052 vol $8.02 each	0
Filed 2025-05-30 17:26 Tx date 2025-05-29	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$529,651 +66,052 vol $8.02 each	66,052
Filed 2025-05-30 17:25 Tx date 2025-05-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,059,552.1524 -131,964 vol $8.03 each	0
Filed 2025-05-30 17:24 Tx date 2025-05-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,059,552 +131,964 vol $8.03 each	131,964
Filed 2025-05-30 17:22 Tx date 2025-05-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-538,050.219 -65,982 vol $8.15 each	0
Filed 2025-05-30 17:21 Tx date 2025-05-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$538,050 +65,982 vol $8.15 each	65,982
Filed 2025-05-23 17:49 Tx date 2025-05-23	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-496,803.0795 -60,879 vol $8.16 each	0
Filed 2025-05-23 17:49 Tx date 2025-05-23	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$496,803 +60,879 vol $8.16 each	60,879
Filed 2025-05-23 17:48 Tx date 2025-05-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-500,003.3572 -59,662 vol $8.38 each	0
Filed 2025-05-23 17:48 Tx date 2025-05-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$500,003 +59,662 vol $8.38 each	59,662
Filed 2025-05-23 17:47 Tx date 2025-05-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-496,739.8912 -60,074 vol $8.27 each	0
Filed 2025-05-23 17:47 Tx date 2025-05-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$496,739 +60,074 vol $8.27 each	60,074
Filed 2025-05-23 17:46 Tx date 2025-05-20	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-495,141.0828 -60,879 vol $8.13 each	0
Filed 2025-05-23 17:46 Tx date 2025-05-20	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$495,141 +60,879 vol $8.13 each	60,879
Filed 2025-05-23 17:45 Tx date 2025-05-19	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-484,431.9777 -60,237 vol $8.04 each	0
Filed 2025-05-23 17:45 Tx date 2025-05-19	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$484,431 +60,237 vol $8.04 each	60,237
Filed 2025-05-20 12:49 Tx date 2025-05-16	$AUPH Aurinia Pharmaceuticals Inc.	Nova, Tina 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$519,350 +63,724 vol $8.15 each	63,724
Filed 2025-05-20 12:44 Tx date 2025-05-15	$AUPH Aurinia Pharmaceuticals Inc.	Nova, Tina 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2025-05-20 12:38 Tx date 2025-05-16	$AUPH Aurinia Pharmaceuticals Inc.	Goetz, Kathleen 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$519,350 +63,724 vol $8.15 each	63,724
Filed 2025-05-20 12:36 Tx date 2025-05-15	$AUPH Aurinia Pharmaceuticals Inc.	Goetz, Kathleen 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2025-05-20 12:32 Tx date 2025-05-16	$AUPH Aurinia Pharmaceuticals Inc.	Johnson, Craig 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$305,502 +37,485 vol $8.15 each	69,173
Filed 2025-05-20 12:18 Tx date 2025-05-16	$AUPH Aurinia Pharmaceuticals Inc.	Bailey, Jeff 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$305,502 +37,485 vol $8.15 each	85,085
Filed 2025-05-16 16:32 Tx date 2025-05-16	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-403,389.0283 -49,421 vol $8.16 each	0
Filed 2025-05-16 16:32 Tx date 2025-05-16	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$403,389 +49,421 vol $8.16 each	49,421
Filed 2025-05-16 16:31 Tx date 2025-05-15	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-398,237.553 -50,355 vol $7.91 each	0
Filed 2025-05-16 16:31 Tx date 2025-05-15	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$398,237 +50,355 vol $7.91 each	50,355
Filed 2025-05-16 16:30 Tx date 2025-05-14	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-768,484.5564 -98,843 vol $7.77 each	0
Filed 2025-05-16 16:30 Tx date 2025-05-14	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$768,484 +98,843 vol $7.77 each	98,843
Filed 2025-05-16 16:29 Tx date 2025-05-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-783,039.5334 -98,678 vol $7.94 each	0
Filed 2025-05-16 16:29 Tx date 2025-05-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$783,039 +98,678 vol $7.94 each	98,678
Filed 2025-05-16 16:28 Tx date 2025-05-12	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-402,124.0804 -49,364 vol $8.15 each	0
Filed 2025-05-16 16:28 Tx date 2025-05-12	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$402,124 +49,364 vol $8.15 each	49,364
Filed 2025-05-09 16:52 Tx date 2025-05-09	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-856,798.038 -106,926 vol $8.01 each	0
Filed 2025-05-09 16:52 Tx date 2025-05-09	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$856,798 +106,926 vol $8.01 each	106,926
Filed 2025-05-09 16:52 Tx date 2025-05-08	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-475,801.7643 -59,001 vol $8.06 each	0
Filed 2025-05-09 16:51 Tx date 2025-05-08	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$475,801 +59,001 vol $8.06 each	59,001
Filed 2025-05-09 16:51 Tx date 2025-05-07	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-474,666.376 -58,595 vol $8.10 each	0
Filed 2025-05-09 16:50 Tx date 2025-05-07	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$474,666 +58,595 vol $8.10 each	58,595
Filed 2025-05-09 16:50 Tx date 2025-05-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-475,848.9376 -58,252 vol $8.17 each	0
Filed 2025-05-09 16:49 Tx date 2025-05-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$475,848 +58,252 vol $8.17 each	58,252
Filed 2025-05-09 16:49 Tx date 2025-05-05	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-485,193.10 -58,457 vol $8.30 each	0
Filed 2025-05-09 16:48 Tx date 2025-05-05	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$485,193 +58,457 vol $8.30 each	58,457
Filed 2025-05-02 16:40 Tx date 2025-05-02	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-538,829.6914 -65,191 vol $8.27 each	0
Filed 2025-05-02 16:39 Tx date 2025-05-02	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$538,829 +65,191 vol $8.27 each	65,191
Filed 2025-05-02 16:38 Tx date 2025-05-01	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-541,147.0415 -65,741 vol $8.23 each	0
Filed 2025-05-02 16:37 Tx date 2025-05-01	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$539,963 +65,741 vol $8.21 each	65,741
Filed 2025-05-02 16:36 Tx date 2025-04-30	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-539,260.2748 -65,741 vol $8.20 each	0
Filed 2025-05-02 16:36 Tx date 2025-04-30	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$539,260 +65,741 vol $8.20 each	65,741
Filed 2025-05-02 16:34 Tx date 2025-04-29	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-519,813.4765 -64,457 vol $8.06 each	0
Filed 2025-05-02 16:33 Tx date 2025-04-29	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$519,813 +64,457 vol $8.06 each	64,457
Filed 2025-05-02 16:32 Tx date 2025-04-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-524,815.8736 -64,709 vol $8.11 each	0
Filed 2025-05-02 16:32 Tx date 2025-04-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$524,815 +64,709 vol $8.11 each	64,709
Filed 2025-04-25 16:20 Tx date 2025-04-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-531,676.467 -65,421 vol $8.13 each	0
Filed 2025-04-25 16:20 Tx date 2025-04-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$531,676 +65,421 vol $8.13 each	65,421
Filed 2025-04-25 16:19 Tx date 2025-04-24	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-578,743.6736 -72,517 vol $7.98 each	0
Filed 2025-04-25 16:18 Tx date 2025-04-24	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$578,743 +72,517 vol $7.98 each	72,517
Filed 2025-04-25 16:18 Tx date 2025-04-23	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-532,134.414 -65,421 vol $8.13 each	0
Filed 2025-04-25 16:17 Tx date 2025-04-23	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$532,134 +65,421 vol $8.13 each	65,421
Filed 2025-04-25 16:17 Tx date 2025-04-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-974,533.8109 -124,007 vol $7.86 each	0
Filed 2025-04-25 16:15 Tx date 2025-04-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$974,533 +124,007 vol $7.86 each	124,007
Filed 2025-04-25 16:15 Tx date 2025-04-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,013,339.7821 -130,843 vol $7.74 each	0
Filed 2025-04-25 16:14 Tx date 2025-04-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,013,339 +130,843 vol $7.74 each	130,843
Filed 2025-04-18 18:20 Tx date 2025-04-17	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,037,602.984 -134,530 vol $7.71 each	0
Filed 2025-04-18 18:20 Tx date 2025-04-17	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,037,602 +134,530 vol $7.71 each	134,530
Filed 2025-04-18 18:19 Tx date 2025-04-16	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,027,084.994 -133,796 vol $7.68 each	0
Filed 2025-04-18 18:19 Tx date 2025-04-16	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,027,084 +133,796 vol $7.68 each	133,796
Filed 2025-04-18 18:19 Tx date 2025-04-15	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,040,872.063 -134,530 vol $7.74 each	0
Filed 2025-04-18 18:18 Tx date 2025-04-15	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,040,872 +134,530 vol $7.74 each	134,530
Filed 2025-04-18 18:18 Tx date 2025-04-14	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,029,531.184 -134,530 vol $7.65 each	0
Filed 2025-04-18 18:17 Tx date 2025-04-14	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,029,531 +134,530 vol $7.65 each	134,530
Filed 2025-04-11 16:47 Tx date 2025-04-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,004,057.738 -135,515 vol $7.41 each	0
Filed 2025-04-11 16:47 Tx date 2025-04-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,004,057 +135,515 vol $7.41 each	135,515
Filed 2025-04-11 16:46 Tx date 2025-04-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,001,870.7379 -136,679 vol $7.33 each	0
Filed 2025-04-11 16:45 Tx date 2025-04-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,001,870 +136,679 vol $7.33 each	136,679
Filed 2025-04-11 16:45 Tx date 2025-04-09	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-971,437.344 -136,480 vol $7.12 each	0
Filed 2025-04-11 16:44 Tx date 2025-04-09	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$971,437 +136,480 vol $7.12 each	136,480
Filed 2025-04-11 16:44 Tx date 2025-04-08	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,006,778.992 -135,584 vol $7.43 each	0
Filed 2025-04-11 16:43 Tx date 2025-04-08	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,006,778 +135,584 vol $7.43 each	135,584
Filed 2025-04-11 16:43 Tx date 2025-04-07	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,035,484.4838 -136,929 vol $7.56 each	0
Filed 2025-04-11 16:43 Tx date 2025-04-07	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,035,484 +136,929 vol $7.56 each	136,929
Filed 2025-04-04 17:06 Tx date 2025-04-04	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,248,549.687 -159,390 vol $7.83 each	0
Filed 2025-04-04 17:05 Tx date 2025-04-04	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,248,549 +159,390 vol $7.83 each	159,390
Filed 2025-04-04 17:05 Tx date 2025-04-03	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-881,714.6156 -110,162 vol $8.00 each	0
Filed 2025-04-04 17:04 Tx date 2025-04-03	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$881,714 +110,162 vol $8.00 each	110,162
Filed 2025-04-04 17:03 Tx date 2025-04-02	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-643,871.844 -79,695 vol $8.08 each	0
Filed 2025-04-04 17:03 Tx date 2025-04-02	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$643,871 +79,695 vol $8.08 each	79,695
Filed 2025-04-04 17:02 Tx date 2025-04-01	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-644,996.1936 -79,582 vol $8.10 each	0
Filed 2025-04-04 17:02 Tx date 2025-04-01	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$644,996 +79,582 vol $8.10 each	79,582
Filed 2025-04-04 17:01 Tx date 2025-03-31	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-673,093.1944 -83,908 vol $8.02 each	0
Filed 2025-04-04 17:01 Tx date 2025-03-31	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$673,093 +83,908 vol $8.02 each	83,908
Filed 2025-03-28 19:56 Tx date 2025-03-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-768,049.8654 -92,991 vol $8.26 each	0
Filed 2025-03-28 19:55 Tx date 2025-03-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$768,049 +92,991 vol $8.26 each	92,991
Filed 2025-03-28 19:54 Tx date 2025-03-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-796,598.1024 -92,991 vol $8.57 each	0
Filed 2025-03-28 19:54 Tx date 2025-03-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$796,598 +92,991 vol $8.57 each	92,991
Filed 2025-03-28 19:54 Tx date 2025-03-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-792,534.3957 -92,991 vol $8.52 each	0
Filed 2025-03-28 19:53 Tx date 2025-03-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$792,534 +92,991 vol $8.52 each	92,991
Filed 2025-03-28 19:52 Tx date 2025-03-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-788,400.5173 -92,147 vol $8.56 each	0
Filed 2025-03-28 19:52 Tx date 2025-03-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$788,400 +92,147 vol $8.56 each	92,147
Filed 2025-03-28 19:51 Tx date 2025-03-24	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-712,910.946 -83,572 vol $8.53 each	0
Filed 2025-03-28 19:51 Tx date 2025-03-24	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$712,910 +83,572 vol $8.53 each	83,572
Filed 2025-03-21 18:32 Tx date 2025-03-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-802,002.9105 -94,749 vol $8.46 each	0
Filed 2025-03-21 18:32 Tx date 2025-03-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$802,002 +94,749 vol $8.46 each	94,749
Filed 2025-03-21 18:31 Tx date 2025-03-20	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-784,611.5175 -93,657 vol $8.38 each	0
Filed 2025-03-21 18:31 Tx date 2025-03-20	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$784,611 +93,657 vol $8.38 each	93,657
Filed 2025-03-21 18:30 Tx date 2025-03-19	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-774,972.4238 -93,287 vol $8.31 each	0
Filed 2025-03-21 18:30 Tx date 2025-03-19	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$774,972 +93,287 vol $8.31 each	93,287
Filed 2025-03-21 18:29 Tx date 2025-03-18	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-783,831.2544 -94,748 vol $8.27 each	0
Filed 2025-03-21 18:29 Tx date 2025-03-18	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$783,831 +94,748 vol $8.27 each	94,748
Filed 2025-03-21 18:28 Tx date 2025-03-17	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-788,444.3286 -94,749 vol $8.32 each	0
Filed 2025-03-21 18:28 Tx date 2025-03-17	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$788,444 +94,749 vol $8.32 each	94,749
Filed 2025-03-14 17:56 Tx date 2025-03-14	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-701,412.3266 -84,926 vol $8.26 each	0
Filed 2025-03-14 17:56 Tx date 2025-03-14	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$701,412 +84,926 vol $8.26 each	84,926
Filed 2025-03-14 17:55 Tx date 2025-03-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-691,474.3644 -84,284 vol $8.20 each	0
Filed 2025-03-14 17:55 Tx date 2025-03-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$691,474 +84,284 vol $8.20 each	84,284
Filed 2025-03-14 17:54 Tx date 2025-03-12	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-674,961.7322 -82,427 vol $8.19 each	0
Filed 2025-03-14 17:53 Tx date 2025-03-12	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$674,961 +82,427 vol $8.19 each	82,427
Filed 2025-03-14 17:53 Tx date 2025-03-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-679,610.439 -82,395 vol $8.25 each	0
Filed 2025-03-14 17:51 Tx date 2025-03-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$679,610 +82,395 vol $8.25 each	82,395
Filed 2025-03-14 17:51 Tx date 2025-03-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-677,441.9148 -84,507 vol $8.02 each	0
Filed 2025-03-14 17:50 Tx date 2025-03-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$677,441 +84,507 vol $8.02 each	84,507
Filed 2025-03-11 14:10 Tx date 2023-12-31	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-50,000 vol	448,673
Filed 2025-03-11 14:09 Tx date 2023-12-31	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-132,440 vol	498,673
Filed 2025-03-11 14:06 Tx date 2023-12-31	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-126,500 vol	665,015
Filed 2025-03-11 14:04 Tx date 2023-12-31	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-412,776 vol	2,951,212
Filed 2025-03-08 10:05 Tx date 2024-11-07	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		9,829
Filed 2025-03-08 10:04 Tx date 2023-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+33,373 vol	33,373
Filed 2025-03-08 09:47 Tx date 2025-03-07	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-137,334.01 -16,687 vol $8.23 each	72,011
Filed 2025-03-08 09:43 Tx date 2025-03-07	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+8,382 vol	18,890
Filed 2024-11-13 11:09 Tx date 2023-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+43,203 vol
Filed 2024-11-13 10:56 Tx date 2023-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+50,060 vol
Filed 2024-11-13 10:38 Tx date 2024-11-07	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2025-03-07 17:41 Tx date 2025-03-07	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-548,088.618 -66,836 vol $8.20 each	0
Filed 2025-03-07 17:40 Tx date 2025-03-07	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$548,088 +66,836 vol $8.20 each	66,836
Filed 2025-03-07 17:39 Tx date 2025-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-564,796.164 -67,062 vol $8.42 each	0
Filed 2025-03-07 17:39 Tx date 2025-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$564,796 +67,062 vol $8.42 each	67,062
Filed 2025-03-07 17:39 Tx date 2025-03-05	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-580,542.3216 -67,062 vol $8.66 each	0
Filed 2025-03-07 17:38 Tx date 2025-03-05	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$580,542 +67,062 vol $8.66 each	67,062
Filed 2025-03-07 17:38 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-855,117.648 -108,240 vol $7.90 each	0
Filed 2025-03-07 17:37 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$855,117 +108,240 vol $7.90 each	108,240
Filed 2025-03-07 17:37 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-974,213.1265 -121,955 vol $7.99 each	0
Filed 2025-03-07 17:36 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$974,213 +121,955 vol $7.99 each	121,955
Filed 2025-03-07 15:53 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$2,227,104 +281,200 vol $7.92 each	5,140,591
Filed 2025-03-07 15:52 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$666,056 +83,257 vol $8.00 each	4,859,391
Filed 2025-03-07 15:51 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$454,981 +56,240 vol $8.09 each	4,776,134
Filed 2025-03-07 15:51 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$1,587,502 +197,943 vol $8.02 each	4,719,894
Filed 2025-03-07 15:50 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$451,460 +56,645 vol $7.97 each	4,521,951
Filed 2025-03-07 15:49 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$1,762,756 +224,555 vol $7.85 each	4,465,306
Filed 2025-03-07 15:48 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners International, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$1,732,896 +218,800 vol $7.92 each	4,388,909
Filed 2025-03-07 15:48 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners International, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$518,248 +64,781 vol $8.00 each	4,170,109
Filed 2025-03-07 15:47 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners International, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$354,018 +43,760 vol $8.09 each	4,105,328
Filed 2025-03-07 15:46 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners International, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$1,235,232 +154,019 vol $8.02 each	4,061,568
Filed 2025-03-07 15:46 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners International, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$351,277 +44,075 vol $7.97 each	3,907,549
Filed 2025-03-07 15:45 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners International, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$1,371,591 +174,725 vol $7.85 each	3,863,474
Filed 2025-03-07 15:43 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners International, LP (Control or Direction)	Common Shares 97 - Other	+3,688,749 vol	3,688,749
Filed 2025-03-07 15:42 Tx date 2024-09-12	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners International, LP (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2025-03-07 15:41 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners, LP (Control or Direction)	Common Shares 97 - Other	-3,688,749 vol	4,240,751
Filed 2025-03-05 18:27 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$3,351,996 +443,973 vol $7.55 each	3,807,961
Filed 2025-03-05 18:25 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 57 - Exercise of rights	$-1,334,816 -166,852 vol $8.00 each	457,581
Filed 2025-03-05 18:23 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+333,705 vol	624,433
Filed 2025-03-05 18:21 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+290,728 vol	290,728
Filed 2025-03-05 18:19 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-1,761,954.48 -222,469 vol $7.92 each	663,495
Filed 2025-03-05 18:18 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-824,313.60 -104,080 vol $7.92 each	885,964
Filed 2025-03-05 18:16 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-1,764,096 -220,512 vol $8.00 each	990,044
Filed 2025-03-05 18:14 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+110,095 vol	667,869
Filed 2025-03-05 18:12 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+51,507 vol	557,774
Filed 2025-03-05 18:10 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+82,603 vol	506,267
Filed 2025-03-05 18:09 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+109,168 vol	423,664
Filed 2025-03-05 18:07 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+2,938 vol	314,496
Filed 2025-03-05 15:17 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+62,583 vol	62,583
Filed 2025-03-05 15:15 Tx date 2024-11-07	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 00 - Opening Balance-Initial SEDI Report
Filed 2025-03-05 15:15 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-181,976 -22,747 vol $8.00 each	88,698
Filed 2025-03-05 15:13 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+10,508 vol	10,508
Filed 2025-03-05 14:14 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+22,554 vol	130,852
Filed 2025-03-05 13:59 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$969,706 +128,438 vol $7.55 each	749,909
Filed 2025-03-05 13:57 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 57 - Exercise of rights	$-409,616 -51,202 vol $8.00 each	135,310
Filed 2025-03-05 13:55 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+102,406 vol	186,512
Filed 2025-03-05 13:54 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+84,106 vol	84,106
Filed 2025-03-05 13:52 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-540,698.40 -68,270 vol $7.92 each	197,757
Filed 2025-03-05 13:51 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-274,776.48 -34,694 vol $7.92 each	266,027
Filed 2025-03-05 13:49 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-517,944 -64,743 vol $8.00 each	300,721
Filed 2025-03-05 13:38 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+30,074 vol	176,199
Filed 2025-03-05 13:36 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+15,283 vol	146,125
Filed 2025-03-05 13:35 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+22,544 vol	130,842
Filed 2025-03-05 13:35 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+22,544 vol
Filed 2025-03-05 13:30 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+28,519 vol	108,298
Filed 2025-03-05 13:24 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+1,419 vol	79,779
Filed 2025-03-05 13:04 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$954,440 +126,416 vol $7.55 each	917,931
Filed 2025-03-05 13:02 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 57 - Exercise of rights	$-542,256 -67,782 vol $8.00 each	150,566
Filed 2025-03-05 12:59 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+135,567 vol	218,348
Filed 2025-03-05 12:58 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+82,781 vol	82,781
Filed 2025-03-05 12:56 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-715,793.76 -90,378 vol $7.92 each	234,822
Filed 2025-03-05 12:55 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-274,776.48 -34,694 vol $7.92 each	325,200
Filed 2025-03-05 12:52 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-577,776 -72,222 vol $8.00 each	359,894
Filed 2025-03-05 12:47 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+47,751 vol	295,077
Filed 2025-03-05 12:46 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+18,330 vol	247,326
Filed 2025-03-05 12:44 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+35,876 vol	228,996
Filed 2025-03-05 12:42 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+38,226 vol	193,120
Filed 2025-03-05 12:40 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+2,938 vol	154,894
Filed 2025-03-05 11:07 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$939,167 +124,393 vol $7.55 each	755,506
Filed 2025-03-05 11:00 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-605,674.08 -76,474 vol $7.92 each	207,243
Filed 2025-03-05 10:56 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-274,776.48 -34,694 vol $7.92 each	283,717
Filed 2025-03-05 10:54 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-523,072 -65,384 vol $8.00 each	318,411
Filed 2025-03-05 10:50 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 57 - Exercise of rights	$-458,832 -57,354 vol $8.00 each	138,814
Filed 2025-03-05 10:45 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+114,711 vol	196,168
Filed 2025-03-05 10:41 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+81,457 vol	81,457
Filed 2025-03-05 10:35 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+37,845 vol	231,304
Filed 2025-03-05 10:34 Tx date 2025-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+17,169 vol	193,459
Filed 2025-03-05 10:32 Tx date 2025-03-03	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+28,448 vol	176,290
Filed 2025-03-05 10:30 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+32,431 vol	147,842
Filed 2025-03-05 10:23 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+3,278 vol	115,411
Filed 2025-02-28 16:48 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-821,580.864 -105,040 vol $7.82 each	0
Filed 2025-02-28 16:48 Tx date 2025-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$821,580 +105,040 vol $7.82 each	105,040
Filed 2025-02-28 16:47 Tx date 2025-02-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-785,142.488 -105,040 vol $7.47 each	0
Filed 2025-02-28 16:47 Tx date 2025-02-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$785,142 +105,040 vol $7.47 each	105,040
Filed 2025-02-28 16:47 Tx date 2025-02-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-839,658.248 -105,040 vol $7.99 each	0
Filed 2025-02-28 16:46 Tx date 2025-02-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$839,658 +105,040 vol $7.99 each	105,040
Filed 2025-02-28 16:46 Tx date 2025-02-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-431,319.0952 -53,816 vol $8.01 each	0
Filed 2025-02-28 16:45 Tx date 2025-02-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$431,319 +53,816 vol $8.01 each	53,816
Filed 2025-02-28 16:45 Tx date 2025-02-24	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-425,752.6308 -52,564 vol $8.10 each	0
Filed 2025-02-28 16:44 Tx date 2025-02-24	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$425,752 +52,564 vol $8.10 each	52,564
Filed 2025-02-21 17:21 Tx date 2025-02-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-838,714.8536 -106,444 vol $7.88 each	0
Filed 2025-02-21 17:21 Tx date 2025-02-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$838,714 +106,444 vol $7.88 each	106,444
Filed 2025-02-21 17:20 Tx date 2025-02-20	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-832,030.1704 -106,444 vol $7.82 each	0
Filed 2025-02-21 17:19 Tx date 2025-02-20	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$832,030 +106,444 vol $7.82 each	106,444
Filed 2025-02-21 17:16 Tx date 2025-02-19	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-846,666.2204 -106,444 vol $7.95 each	0
Filed 2025-02-21 17:15 Tx date 2025-02-19	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$846,666 +106,444 vol $7.95 each	106,444
Filed 2025-02-21 17:14 Tx date 2025-02-18	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-802,366.033 -100,459 vol $7.99 each	0
Filed 2025-02-21 17:13 Tx date 2025-02-18	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$802,366 +100,459 vol $7.99 each	100,459
Filed 2025-02-21 12:09 Tx date 2025-02-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-565,826.3988 -68,468 vol $8.26 each	0
Filed 2025-02-21 12:07 Tx date 2025-02-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$565,826 +68,468 vol $8.26 each	68,468
Filed 2025-02-07 17:00 Tx date 2025-02-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-600,998.4084 -72,724 vol $8.26 each
Filed 2025-02-07 17:00 Tx date 2025-02-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$600,998 +72,724 vol $8.26 each
Filed 2025-02-14 17:18 Tx date 2025-02-14	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-951,644.7615 -120,585 vol $7.89 each	0
Filed 2025-02-14 17:18 Tx date 2025-02-14	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$951,644 +120,585 vol $7.89 each	120,585
Filed 2025-02-14 17:17 Tx date 2025-02-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-956,685.2145 -120,585 vol $7.93 each	0
Filed 2025-02-14 17:17 Tx date 2025-02-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$956,685 +120,585 vol $7.93 each	120,585
Filed 2025-02-14 17:16 Tx date 2025-02-12	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-914,613.4404 -118,764 vol $7.70 each	0
Filed 2025-02-14 17:15 Tx date 2025-02-12	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$914,613 +118,764 vol $7.70 each	118,764
Filed 2025-02-14 17:15 Tx date 2025-02-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-891,514.7208 -115,156 vol $7.74 each	0
Filed 2025-02-14 17:14 Tx date 2025-02-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$891,514 +115,156 vol $7.74 each	115,156
Filed 2025-02-14 17:13 Tx date 2025-02-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-911,812.056 -114,384 vol $7.97 each	0
Filed 2025-02-14 17:13 Tx date 2025-02-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$911,812 +114,384 vol $7.97 each	114,384
Filed 2025-02-07 17:02 Tx date 2025-02-07	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-649,739.9724 -81,019 vol $8.02 each	0
Filed 2025-02-07 17:01 Tx date 2025-02-07	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$649,739 +81,019 vol $8.02 each	81,019
Filed 2025-02-07 17:00 Tx date 2025-02-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-600,998.4084 -72,724 vol $8.26 each	0
Filed 2025-02-07 17:00 Tx date 2025-02-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$600,998 +72,724 vol $8.26 each	72,724
Filed 2025-02-07 16:59 Tx date 2025-02-05	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-556,787.068 -67,720 vol $8.22 each	0
Filed 2025-02-07 16:59 Tx date 2025-02-05	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$556,787 +67,720 vol $8.22 each	67,720
Filed 2025-02-07 16:58 Tx date 2025-02-04	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-954,504.008 -120,808 vol $7.90 each	0
Filed 2025-02-07 16:57 Tx date 2025-02-04	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$954,504 +120,808 vol $7.90 each	120,808
Filed 2025-02-07 16:57 Tx date 2025-02-03	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,060,214.8905 -136,645 vol $7.76 each	0
Filed 2025-02-07 16:56 Tx date 2025-02-03	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,060,214 +136,645 vol $7.76 each	136,645
Filed 2025-01-31 17:34 Tx date 2025-01-31	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,079,643.0824 -135,236 vol $7.98 each	0
Filed 2025-01-31 17:34 Tx date 2025-01-31	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,079,643 +135,236 vol $7.98 each	135,236
Filed 2025-01-31 17:33 Tx date 2025-01-30	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-650,537.7792 -80,768 vol $8.05 each	0
Filed 2025-01-31 17:33 Tx date 2025-01-30	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$650,537 +80,768 vol $8.05 each	80,768
Filed 2025-01-31 17:32 Tx date 2025-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-592,705.9359 -72,473 vol $8.18 each	0
Filed 2025-01-31 17:32 Tx date 2025-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$592,705 +72,473 vol $8.18 each	72,473
Filed 2025-01-31 17:31 Tx date 2025-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-623,579.1243 -74,483 vol $8.37 each	0
Filed 2025-01-31 17:31 Tx date 2025-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$623,579 +74,483 vol $8.37 each	74,483
Filed 2025-01-31 17:30 Tx date 2025-01-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-607,073.6915 -74,483 vol $8.15 each	0
Filed 2025-01-31 17:30 Tx date 2025-01-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$607,073 +74,483 vol $8.15 each	74,483
Filed 2025-01-24 16:50 Tx date 2025-01-24	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-541,948.9964 -67,358 vol $8.05 each	0
Filed 2025-01-24 16:49 Tx date 2025-01-24	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$541,948 +67,358 vol $8.05 each	67,358
Filed 2025-01-24 16:49 Tx date 2025-01-23	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,084,609.977 -137,730 vol $7.87 each	0
Filed 2025-01-24 16:48 Tx date 2025-01-23	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,084,609 +137,730 vol $7.87 each	137,730
Filed 2025-01-24 16:48 Tx date 2025-01-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,065,355.323 -137,730 vol $7.74 each	0
Filed 2025-01-24 16:47 Tx date 2025-01-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,065,355 +137,730 vol $7.74 each	137,730
Filed 2025-01-24 16:46 Tx date 2025-01-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,082,185.929 -137,730 vol $7.86 each	0
Filed 2025-01-24 16:46 Tx date 2025-01-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,082,185 +137,730 vol $7.86 each	137,730
Filed 2025-01-17 17:42 Tx date 2025-01-17	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-812,805.0362 -103,546 vol $7.85 each	0
Filed 2025-01-17 17:41 Tx date 2025-01-17	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$812,805 +103,546 vol $7.85 each	103,546
Filed 2025-01-17 17:40 Tx date 2025-01-16	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-975,879.0912 -127,104 vol $7.68 each	0
Filed 2025-01-17 17:39 Tx date 2025-01-16	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$975,879 +127,104 vol $7.68 each	127,104
Filed 2025-01-17 17:38 Tx date 2025-01-15	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-969,196.6233 -125,757 vol $7.71 each	0
Filed 2025-01-17 17:37 Tx date 2025-01-15	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$969,196 +125,757 vol $7.71 each	125,757
Filed 2025-01-17 17:35 Tx date 2025-01-14	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-971,462.0592 -126,783 vol $7.66 each	0
Filed 2025-01-17 17:34 Tx date 2025-01-14	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$971,462 +126,783 vol $7.66 each	126,783
Filed 2025-01-17 17:32 Tx date 2025-01-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,103,305.0148 -142,498 vol $7.74 each	0
Filed 2025-01-17 17:30 Tx date 2025-01-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,103,305 +142,498 vol $7.74 each	142,498
Filed 2025-01-10 18:14 Tx date 2025-01-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,102,259.6092 -138,374 vol $7.97 each	0
Filed 2025-01-10 18:14 Tx date 2025-01-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,102,259 +138,374 vol $7.97 each	138,374
Filed 2025-01-10 18:13 Tx date 2025-01-08	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-604,974.1425 -71,871 vol $8.42 each	0
Filed 2025-01-10 18:13 Tx date 2025-01-08	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$604,974 +71,871 vol $8.42 each	71,871
Filed 2025-01-10 18:12 Tx date 2025-01-07	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-609,692.1951 -71,997 vol $8.47 each	0
Filed 2025-01-10 18:11 Tx date 2025-01-07	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$607,532 +71,997 vol $8.44 each	71,997
Filed 2025-01-10 18:11 Tx date 2025-01-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-608,506.2183 -72,109 vol $8.44 each	0
Filed 2025-01-10 18:10 Tx date 2025-01-06	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$608,506 +72,109 vol $8.44 each	72,109
Filed 2025-01-03 19:29 Tx date 2025-01-03	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-627,867.448 -72,280 vol $8.69 each	0
Filed 2025-01-03 19:29 Tx date 2025-01-03	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$627,867 +72,280 vol $8.69 each	72,280
Filed 2025-01-03 19:28 Tx date 2025-01-02	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-641,116.372 -72,280 vol $8.87 each	0
Filed 2025-01-03 19:28 Tx date 2025-01-02	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$641,116 +72,280 vol $8.87 each	72,280
Filed 2025-01-03 19:27 Tx date 2024-12-31	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-556,736.8864 -62,014 vol $8.98 each	0
Filed 2025-01-03 19:27 Tx date 2024-12-31	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$556,736 +62,014 vol $8.98 each	62,014
Filed 2024-12-27 17:53 Tx date 2024-12-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-92,303.45 -10,300 vol $8.96 each	0
Filed 2024-12-27 17:53 Tx date 2024-12-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$92,303 +10,300 vol $8.96 each	10,300
Filed 2024-12-27 17:52 Tx date 2024-12-24	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-623,544.804 -69,561 vol $8.96 each	0
Filed 2024-12-27 17:52 Tx date 2024-12-24	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$623,544 +69,561 vol $8.96 each	69,561
Filed 2024-12-27 17:51 Tx date 2024-12-23	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-680,859.1696 -75,806 vol $8.98 each	0
Filed 2024-12-27 17:51 Tx date 2024-12-23	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$680,859 +75,806 vol $8.98 each	75,806
Filed 2024-12-20 17:06 Tx date 2024-12-20	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-6,272.98 -700 vol $8.96 each	0
Filed 2024-12-20 17:06 Tx date 2024-12-20	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$6,272 +700 vol $8.96 each	700
Filed 2024-12-20 17:05 Tx date 2024-12-19	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-175,167.7325 -19,501 vol $8.98 each	0
Filed 2024-12-20 17:05 Tx date 2024-12-19	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$175,167 +19,501 vol $8.98 each	19,501
Filed 2024-12-20 17:05 Tx date 2024-12-18	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-173,720.8276 -19,324 vol $8.99 each	0
Filed 2024-12-20 17:04 Tx date 2024-12-18	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$173,720 +19,324 vol $8.99 each	19,324
Filed 2024-12-10 16:57 Tx date 2024-12-09	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$4,545,000 +500,000 vol $9.09 each	7,929,500
Filed 2024-12-10 16:55 Tx date 2024-12-06	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$3,604,000 +400,000 vol $9.01 each	7,429,500
Filed 2024-12-10 16:55 Tx date 2024-12-05	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners, LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$2,673,000 +300,000 vol $8.91 each	7,029,500
Filed 2024-11-29 14:59 Tx date 2024-11-29	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-754,339.8221 -84,379 vol $8.94 each	0
Filed 2024-11-29 14:58 Tx date 2024-11-29	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$754,339 +84,379 vol $8.94 each	84,379
Filed 2024-11-29 14:58 Tx date 2024-11-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,349,865.066 -153,098 vol $8.82 each	0
Filed 2024-11-29 14:57 Tx date 2024-11-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,349,865 +153,098 vol $8.82 each	153,098
Filed 2024-11-29 14:57 Tx date 2024-11-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,264,872.7232 -145,001 vol $8.72 each	0
Filed 2024-11-29 14:56 Tx date 2024-11-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,264,872 +145,001 vol $8.72 each	145,001
Filed 2024-11-29 14:55 Tx date 2024-11-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,328,299.2008 -149,708 vol $8.87 each	0
Filed 2024-11-29 14:55 Tx date 2024-11-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,328,299 +149,708 vol $8.87 each	149,708
Filed 2024-11-26 11:21 Tx date 2024-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+12,135 vol	12,135
Filed 2024-11-26 11:20 Tx date 2024-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$153,601 +18,641 vol $8.24 each	204,834
Filed 2024-11-26 11:17 Tx date 2024-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+12,135 vol	12,135
Filed 2024-11-26 11:16 Tx date 2024-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$153,601 +18,641 vol $8.24 each	159,834
Filed 2024-11-26 11:12 Tx date 2024-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Bailey, Jeff 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+12,135 vol	12,135
Filed 2024-11-26 11:11 Tx date 2024-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Bailey, Jeff 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$153,601 +18,641 vol $8.24 each	47,600
Filed 2024-11-26 10:59 Tx date 2024-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Smith, Karen Lesley 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+12,135 vol	12,135
Filed 2024-11-26 10:57 Tx date 2024-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Smith, Karen Lesley 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$153,601 +18,641 vol $8.24 each	47,600
Filed 2024-11-26 10:52 Tx date 2024-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Johnson, Craig 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+20,631 vol	20,631
Filed 2024-11-26 10:50 Tx date 2024-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Johnson, Craig 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$261,109 +31,688 vol $8.24 each	31,688
Filed 2024-11-26 10:48 Tx date 2024-11-07	$AUPH Aurinia Pharmaceuticals Inc.	Johnson, Craig 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2024-11-22 18:42 Tx date 2024-11-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,126,916.6064 -126,438 vol $8.91 each	0
Filed 2024-11-22 18:41 Tx date 2024-11-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,126,916 +126,438 vol $8.91 each	126,438
Filed 2024-11-22 18:40 Tx date 2024-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,710,971.08 -200,020 vol $8.55 each	0
Filed 2024-11-22 18:40 Tx date 2024-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,710,971 +200,020 vol $8.55 each	200,020
Filed 2024-11-22 18:39 Tx date 2024-11-20	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,629,242.908 -200,020 vol $8.15 each	0
Filed 2024-11-22 18:38 Tx date 2024-11-20	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,629,242 +200,020 vol $8.15 each	200,020
Filed 2024-11-22 18:37 Tx date 2024-11-19	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,576,600.06 -195,160 vol $8.08 each	0
Filed 2024-11-22 18:36 Tx date 2024-11-19	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,576,600 +195,160 vol $8.08 each	195,160
Filed 2024-11-22 18:35 Tx date 2024-11-18	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,612,899.992 -200,420 vol $8.05 each	0
Filed 2024-11-22 18:34 Tx date 2024-11-18	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,612,899 +200,420 vol $8.05 each	200,420
Filed 2024-11-15 18:31 Tx date 2024-11-15	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,373,783.5375 -167,975 vol $8.18 each	0
Filed 2024-11-15 18:30 Tx date 2024-11-15	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,373,783 +167,975 vol $8.18 each	167,975
Filed 2024-11-15 18:29 Tx date 2024-11-14	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,361,035.6123 -163,051 vol $8.35 each	0
Filed 2024-11-15 18:28 Tx date 2024-11-14	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,361,035 +163,051 vol $8.35 each	163,051
Filed 2024-11-15 18:25 Tx date 2024-11-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,396,480.316 -168,910 vol $8.27 each	0
Filed 2024-11-15 18:24 Tx date 2024-11-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,396,480 +168,910 vol $8.27 each	168,910
Filed 2024-11-15 18:22 Tx date 2024-11-12	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,421,799.925 -168,910 vol $8.42 each	0
Filed 2024-11-15 18:22 Tx date 2024-11-12	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,421,799 +168,910 vol $8.42 each	168,910
Filed 2024-11-15 18:21 Tx date 2024-11-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,437,474.773 -168,910 vol $8.51 each	0
Filed 2024-11-15 18:21 Tx date 2024-11-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,437,474 +168,910 vol $8.51 each	168,910
Filed 2024-11-13 15:09 Tx date 2024-11-07	$AUPH Aurinia Pharmaceuticals Inc.	Johnson, Craig 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2024-11-13 13:50 Tx date 2024-11-08	$AUPH Aurinia Pharmaceuticals Inc.	Smith, Karen Lesley 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+12,672 vol	12,672
Filed 2024-11-13 13:49 Tx date 2023-08-18	$AUPH Aurinia Pharmaceuticals Inc.	Smith, Karen Lesley 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2024-11-13 13:48 Tx date 2024-11-08	$AUPH Aurinia Pharmaceuticals Inc.	Smith, Karen Lesley 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-17,913 vol	0
Filed 2024-11-13 13:27 Tx date 2024-11-08	$AUPH Aurinia Pharmaceuticals Inc.	Bailey, Jeff 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+13,356 vol	13,356
Filed 2024-11-13 13:26 Tx date 2023-08-18	$AUPH Aurinia Pharmaceuticals Inc.	Bailey, Jeff 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2024-11-13 13:25 Tx date 2024-11-08	$AUPH Aurinia Pharmaceuticals Inc.	Bailey, Jeff 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-17,913 vol	0
Filed 2024-11-13 11:09 Tx date 2023-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+43,203 vol	43,203
Filed 2024-11-13 10:58 Tx date 2024-01-30	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+68,242 vol	118,302
Filed 2024-11-13 10:56 Tx date 2023-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+50,060 vol
Filed 2024-11-13 10:56 Tx date 2023-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+50,060 vol	50,060
Filed 2024-11-13 10:52 Tx date 2024-11-07	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2024-11-13 10:51 Tx date 2023-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$737,090 +81,990 vol $8.99 each	81,990
Filed 2024-11-13 10:44 Tx date 2024-11-07	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2024-11-13 10:38 Tx date 2024-11-07	$AUPH Aurinia Pharmaceuticals Inc.	Keenan, Greg 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2024-11-11 08:56 Tx date 2024-11-08	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-655,413.7512 -79,612 vol $8.23 each	0
Filed 2024-11-11 08:55 Tx date 2024-11-08	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$655,413 +79,612 vol $8.23 each	79,612
Filed 2024-10-23 12:07 Tx date 2024-10-18	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners, LP (Control or Direction)	Options 52 - Expiration of options	$-180,000 -30,000 vol $6.00 each	0
Filed 2024-09-22 21:49 Tx date 2024-09-12	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners, LP (Control or Direction)	Options 00 - Opening Balance-Initial SEDI Report		30,000
Filed 2024-09-22 21:45 Tx date 2024-09-12	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners III, Inc. (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		500,000
Filed 2024-09-22 21:44 Tx date 2024-09-12	$AUPH Aurinia Pharmaceuticals Inc.	Tang, Kevin 4 - Director of Issuer Holder: Tang Capital Partners, LP (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		6,729,500
Filed 2024-08-08 09:26 Tx date 2024-08-06	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+27,595 vol	101,523
Filed 2024-08-08 09:24 Tx date 2024-08-06	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-243,431.64 -45,844 vol $5.31 each	354,815
Filed 2024-05-23 09:47 Tx date 2024-05-21	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-9,310 vol	0
Filed 2024-05-23 09:39 Tx date 2024-05-21	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,700 vol	12,918
Filed 2024-05-23 09:38 Tx date 2024-05-21	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-9,310 vol	0
Filed 2024-05-23 09:35 Tx date 2024-05-21	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+4,364 vol	44,364
Filed 2024-05-23 09:34 Tx date 2024-05-21	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-9,310 vol	0
Filed 2024-05-23 09:30 Tx date 2024-05-21	$AUPH Aurinia Pharmaceuticals Inc.	Balakrishnan, Brinda 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+8,790 vol	17,523
Filed 2024-05-23 09:28 Tx date 2024-05-21	$AUPH Aurinia Pharmaceuticals Inc.	Balakrishnan, Brinda 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-9,310 vol	0
Filed 2024-05-23 09:21 Tx date 2024-05-21	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+4,058 vol	28,141
Filed 2024-05-23 09:19 Tx date 2024-05-21	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-9,310 vol
Filed 2024-05-22 17:17 Tx date 2024-05-21	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	$-32,316.20 -5,630 vol $5.74 each	7,595
Filed 2024-05-22 17:15 Tx date 2024-05-20	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+9,310 vol	13,225
Filed 2024-05-22 17:13 Tx date 2024-05-20	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-9,310 vol	0
Filed 2024-05-16 10:19 Tx date 2024-05-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-4,446.09 -891 vol $4.99 each	0
Filed 2024-05-16 10:19 Tx date 2024-05-13	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$4,446 +891 vol $4.99 each	891
Filed 2024-05-01 08:59 Tx date 2024-04-30	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-37,923.6693 -7,601 vol $4.99 each	0
Filed 2024-05-01 08:59 Tx date 2024-04-30	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$37,923 +7,601 vol $4.99 each	7,601
Filed 2024-05-01 08:58 Tx date 2024-04-29	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-404,518.7169 -81,087 vol $4.99 each	0
Filed 2024-05-01 08:58 Tx date 2024-04-29	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$404,518 +81,087 vol $4.99 each	81,087
Filed 2024-05-01 08:57 Tx date 2024-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-660,491.5356 -133,627 vol $4.94 each	0
Filed 2024-05-01 08:57 Tx date 2024-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$660,491 +133,627 vol $4.94 each	133,627
Filed 2024-04-25 17:58 Tx date 2024-04-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-646,816.9608 -133,524 vol $4.84 each	0
Filed 2024-04-25 17:58 Tx date 2024-04-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$646,816 +133,524 vol $4.84 each	133,524
Filed 2024-04-25 17:57 Tx date 2024-04-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-296,562.6558 -59,601 vol $4.98 each	0
Filed 2024-04-25 17:56 Tx date 2024-04-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$296,562 +59,601 vol $4.98 each	59,601
Filed 2024-04-21 15:30 Tx date 2024-04-19	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-664,983.4612 -135,994 vol $4.89 each	0
Filed 2024-04-21 15:29 Tx date 2024-04-19	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$664,983 +135,994 vol $4.89 each	135,994
Filed 2024-04-21 15:25 Tx date 2024-04-18	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-669,333.7125 -138,375 vol $4.84 each	0
Filed 2024-04-21 15:24 Tx date 2024-04-18	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$669,333 +138,375 vol $4.84 each	138,375
Filed 2024-04-21 15:23 Tx date 2024-04-17	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-687,101.0625 -138,375 vol $4.97 each	0
Filed 2024-04-21 15:22 Tx date 2024-04-17	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$687,101 +138,375 vol $4.97 each	138,375
Filed 2024-04-16 18:05 Tx date 2024-04-16	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-34,091.409 -6,834 vol $4.99 each	0
Filed 2024-04-16 18:05 Tx date 2024-04-16	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$34,091 +6,834 vol $4.99 each	6,834
Filed 2024-04-16 18:04 Tx date 2024-04-12	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-48,892.02 -9,798 vol $4.99 each	0
Filed 2024-04-16 18:04 Tx date 2024-04-12	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$48,892 +9,798 vol $4.99 each	9,798
Filed 2024-04-12 08:46 Tx date 2024-04-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-136,693.12 -27,400 vol $4.99 each	0
Filed 2024-04-12 08:45 Tx date 2024-04-11	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$136,693 +27,400 vol $4.99 each	27,400
Filed 2024-04-12 08:45 Tx date 2024-04-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-643,149.0254 -129,079 vol $4.98 each	0
Filed 2024-04-12 08:44 Tx date 2024-04-10	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$643,149 +129,079 vol $4.98 each	129,079
Filed 2024-04-12 08:43 Tx date 2024-04-09	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-9,424.052 -1,892 vol $4.98 each	0
Filed 2024-04-12 08:43 Tx date 2024-04-09	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$9,424 +1,892 vol $4.98 each	1,892
Filed 2024-04-12 08:42 Tx date 2024-04-08	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-190,455.6762 -38,169 vol $4.99 each	0
Filed 2024-04-12 08:42 Tx date 2024-04-08	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$190,455 +38,169 vol $4.99 each	38,169
Filed 2024-04-01 17:06 Tx date 2024-04-01	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-40,898.32 -8,200 vol $4.99 each	0
Filed 2024-04-01 17:05 Tx date 2024-04-01	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$40,898 +8,200 vol $4.99 each	8,200
Filed 2024-04-01 17:05 Tx date 2024-03-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-305,690.84 -61,300 vol $4.99 each	0
Filed 2024-04-01 17:04 Tx date 2024-03-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$305,690 +61,300 vol $4.99 each	61,300
Filed 2024-03-28 08:46 Tx date 2024-03-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-627,818.6196 -126,281 vol $4.97 each	0
Filed 2024-03-28 08:45 Tx date 2024-03-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$627,818 +126,281 vol $4.97 each	126,281
Filed 2024-03-28 08:44 Tx date 2024-03-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-872,665.8048 -175,104 vol $4.98 each	0
Filed 2024-03-28 08:43 Tx date 2024-03-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$872,665 +175,104 vol $4.98 each	175,104
Filed 2024-03-28 08:42 Tx date 2024-03-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-389,583.1116 -78,126 vol $4.99 each	0
Filed 2024-03-28 08:41 Tx date 2024-03-25	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$389,583 +78,126 vol $4.99 each	78,126
Filed 2024-03-25 09:18 Tx date 2024-03-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-994,884.48 -199,776 vol $4.98 each	0
Filed 2024-03-25 09:18 Tx date 2024-03-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$994,884 +199,776 vol $4.98 each	199,776
Filed 2024-03-08 12:07 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+15,688 vol	101,115
Filed 2024-03-08 12:06 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+9,136 vol	85,427
Filed 2024-03-08 12:05 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-200,110.40 -35,734 vol $5.60 each	92,284
Filed 2024-03-08 12:00 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-116,569.60 -20,816 vol $5.60 each	128,018
Filed 2024-03-08 11:52 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Knappertz, Volker 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+29,459 vol	55,250
Filed 2024-03-08 11:51 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Knappertz, Volker 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-357,392 -63,820 vol $5.60 each	229,517
Filed 2024-03-08 11:25 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-1,245,826.40 -222,469 vol $5.60 each	1,210,556
Filed 2024-03-08 11:20 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-497,982.78 -90,378 vol $5.51 each	432,116
Filed 2024-03-08 11:19 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-191,158.43 -34,693 vol $5.51 each	522,494
Filed 2024-03-08 11:10 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+144,781 vol	311,558
Filed 2024-03-08 11:09 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+54,787 vol	166,777
Filed 2024-03-08 11:07 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-1,245,826.40 -222,469 vol $5.60 each
Filed 2024-03-08 11:05 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-582,848 -104,080 vol $5.60 each	1,433,025
Filed 2024-03-08 10:54 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+38,952 vol	73,928
Filed 2024-03-08 10:53 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-317,682.40 -56,729 vol $5.60 each	400,659
Filed 2024-03-08 10:48 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+61,087 vol	151,956
Filed 2024-03-08 10:48 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+23,319 vol	90,869
Filed 2024-03-08 10:45 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-506,116.80 -90,378 vol $5.60 each	432,116
Filed 2024-03-08 10:45 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-506,116.80 -90,378 vol $5.60 each
Filed 2024-03-08 10:44 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-194,280.80 -34,693 vol $5.60 each	522,494
Filed 2024-03-08 10:44 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-194,280.80 -34,693 vol $5.60 each
Filed 2024-03-08 10:39 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+29,982 vol	78,360
Filed 2024-03-08 10:38 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+15,236 vol	48,378
Filed 2024-03-08 10:37 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-382,312 -68,270 vol $5.60 each	365,464
Filed 2024-03-08 10:34 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-194,280.80 -34,693 vol $5.60 each	433,734
Filed 2024-03-08 10:27 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+52,628 vol	112,133
Filed 2024-03-08 10:26 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+23,727 vol	59,505
Filed 2024-03-08 10:23 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-428,248.80 -76,473 vol $5.60 each	383,795
Filed 2024-03-08 10:21 Tx date 2024-03-06	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-194,280.80 -34,693 vol $5.60 each	460,268
Filed 2024-02-29 10:46 Tx date 2024-02-27	$AUPH Aurinia Pharmaceuticals Inc.	Knappertz, Volker 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$-30,073 -4,930 vol $6.10 each	25,791
Filed 2024-02-29 09:59 Tx date 2024-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-57,507.3055 -9,805 vol $5.87 each	0
Filed 2024-02-29 09:58 Tx date 2024-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$57,507 +9,805 vol $5.87 each	9,805
Filed 2024-02-29 09:58 Tx date 2024-02-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-125,067.6325 -20,975 vol $5.96 each	0
Filed 2024-02-29 09:57 Tx date 2024-02-27	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$125,067 +20,975 vol $5.96 each	20,975
Filed 2024-02-29 09:57 Tx date 2024-02-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,511,269.1848 -252,653 vol $5.98 each	0
Filed 2024-02-29 09:56 Tx date 2024-02-26	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,511,269 +252,653 vol $5.98 each	252,653
Filed 2024-02-26 10:38 Tx date 2024-02-20	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$24,304,900 +4,930 vol $4,930 each	67,550
Filed 2024-02-26 10:37 Tx date 2024-02-20	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+216,666 vol	557,187
Filed 2024-02-26 10:24 Tx date 2024-02-20	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+29,976 vol	34,976
Filed 2024-02-26 10:22 Tx date 2024-02-20	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+195,512 vol	457,388
Filed 2024-02-26 10:21 Tx date 2024-02-20	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-251,219.64 -45,843 vol $5.48 each	261,876
Filed 2024-02-26 09:52 Tx date 2024-02-20	$AUPH Aurinia Pharmaceuticals Inc.	Knappertz, Volker 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+25,791 vol	30,721
Filed 2024-02-26 09:50 Tx date 2024-02-20	$AUPH Aurinia Pharmaceuticals Inc.	Knappertz, Volker 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+4,930 vol	4,930
Filed 2024-02-26 09:49 Tx date 2022-07-18	$AUPH Aurinia Pharmaceuticals Inc.	Knappertz, Volker 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2024-02-26 09:48 Tx date 2024-02-20	$AUPH Aurinia Pharmaceuticals Inc.	Knappertz, Volker 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-279,134.76 -50,937 vol $5.48 each	293,337
Filed 2024-02-26 09:23 Tx date 2024-02-20	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+661,538 vol	1,537,105
Filed 2024-02-26 09:21 Tx date 2024-02-20	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+4,886 vol	111,990
Filed 2024-02-26 09:17 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+71,033 vol	104,000
Filed 2024-02-26 09:11 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-913,822.40 -104,080 vol $8.78 each	875,567
Filed 2023-03-07 10:32 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+71,330 vol
Filed 2023-03-07 10:31 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-930,475.20 -104,080 vol $8.94 each
Filed 2024-02-23 16:40 Tx date 2024-02-23	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-1,064,755.9796 -178,372 vol $5.97 each	0
Filed 2024-02-23 16:40 Tx date 2024-02-23	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$1,064,755 +178,372 vol $5.97 each	178,372
Filed 2024-02-23 16:39 Tx date 2024-02-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-3,418,183.2384 -587,559 vol $5.82 each	0
Filed 2024-02-23 16:38 Tx date 2024-02-22	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$3,418,183 +587,559 vol $5.82 each	587,559
Filed 2024-02-23 16:37 Tx date 2024-02-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-3,823,204.9466 -683,423 vol $5.59 each	0
Filed 2024-02-23 16:36 Tx date 2024-02-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$3,823,204 +683,423 vol $5.59 each	683,423
Filed 2024-02-23 16:33 Tx date 2024-02-21	$AUPH Aurinia Pharmaceuticals Inc.	Aurinia Pharmaceuticals 1 - Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2024-02-23 11:25 Tx date 2024-02-20	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+194,230 vol	468,427
Filed 2024-02-23 11:23 Tx date 2024-02-20	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+4,217 vol	33,142
Filed 2024-02-23 11:21 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-304,604.54 -34,693 vol $8.78 each	274,197
Filed 2024-02-23 11:17 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+15,049 vol	26,731
Filed 2023-03-07 09:46 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+15,291 vol
Filed 2023-03-07 09:39 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-310,155.42 -34,693 vol $8.94 each
Filed 2023-09-27 12:52 Tx date 2023-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Foster, Robert Thomas 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Warrants 99 - Correction of information	-1,250,000 vol	0
Filed 2023-09-27 12:51 Tx date 2023-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Foster, Robert Thomas 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 99 - Correction of information	-3,750,000 vol	32,900
Filed 2023-09-27 12:49 Tx date 2023-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Foster, Robert Thomas 4 - Director of Issuer, 5 - Senior Officer of Issuer Holder: Foster Investments Ltd. (Indirect Ownership)	Common Shares 99 - Correction of information	-4,328,890 vol	0
Filed 2023-09-27 12:48 Tx date 2023-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Foster, Robert Thomas 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 99 - Correction of information	-2,006,820 vol	0
Filed 2023-09-25 12:36 Tx date 2023-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Foster, Robert Thomas 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+20,383 vol	20,383
Filed 2023-09-25 12:33 Tx date 2009-06-23	$AUPH Aurinia Pharmaceuticals Inc.	Foster, Robert Thomas 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2023-09-25 12:30 Tx date 2023-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Foster, Robert Thomas 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$274,386 +32,900 vol $8.34 each	3,782,900
Filed 2023-08-22 14:13 Tx date 2023-08-18	$AUPH Aurinia Pharmaceuticals Inc.	Bailey, Jeff 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+17,913 vol	17,913
Filed 2023-08-22 14:12 Tx date 2023-08-18	$AUPH Aurinia Pharmaceuticals Inc.	Bailey, Jeff 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2023-08-22 14:11 Tx date 2023-08-18	$AUPH Aurinia Pharmaceuticals Inc.	Bailey, Jeff 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$274,820 +28,959 vol $9.49 each	28,959
Filed 2023-08-22 14:08 Tx date 2023-08-18	$AUPH Aurinia Pharmaceuticals Inc.	Bailey, Jeff 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2023-08-22 14:00 Tx date 2023-08-18	$AUPH Aurinia Pharmaceuticals Inc.	Smith, Karen Lesley 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+17,913 vol	17,913
Filed 2023-08-22 13:59 Tx date 2023-08-18	$AUPH Aurinia Pharmaceuticals Inc.	Smith, Karen Lesley 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2023-08-22 13:57 Tx date 2023-08-18	$AUPH Aurinia Pharmaceuticals Inc.	Smith, Karen Lesley 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$274,820 +28,959 vol $9.49 each	28,959
Filed 2023-08-22 13:18 Tx date 2023-08-18	$AUPH Aurinia Pharmaceuticals Inc.	Smith, Karen Lesley 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2023-05-24 15:07 Tx date 2023-05-23	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+8,461 vol	11,961
Filed 2023-05-24 15:05 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-8,733 vol	0
Filed 2023-05-24 15:03 Tx date 2023-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+8,733 vol	78,733
Filed 2023-05-24 15:02 Tx date 2023-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-8,733 vol	0
Filed 2023-05-24 14:59 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$163,613 +15,234 vol $10.74 each	141,193
Filed 2023-05-24 14:57 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+9,310 vol	9,310
Filed 2023-05-24 14:56 Tx date 2023-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,918 vol	9,218
Filed 2023-05-24 14:53 Tx date 2023-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-8,733 vol	0
Filed 2023-05-24 14:44 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$163,613 +15,234 vol $10.74 each	186,193
Filed 2023-05-24 14:43 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+9,310 vol	9,310
Filed 2023-05-24 14:41 Tx date 2023-05-23	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-98,333.58 -8,733 vol $11.26 each	40,000
Filed 2023-05-24 14:40 Tx date 2023-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+8,733 vol	48,733
Filed 2023-05-24 14:37 Tx date 2023-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-8,733 vol	0
Filed 2023-05-24 14:30 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	Balakrishnan, Brinda 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$163,613 +15,234 vol $10.74 each	83,137
Filed 2023-05-24 14:24 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$163,613 +15,234 vol $10.74 each	156,193
Filed 2023-05-24 14:17 Tx date 2023-05-18	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+4,083 vol	24,083
Filed 2023-05-24 14:13 Tx date 2023-05-18	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-8,733 vol	0
Filed 2023-05-24 14:02 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+9,310 vol	9,310
Filed 2023-05-24 14:01 Tx date 2023-05-18	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-8,733 vol
Filed 2023-05-24 13:53 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	Balakrishnan, Brinda 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+9,310 vol	9,310
Filed 2023-05-24 13:49 Tx date 2023-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Balakrishnan, Brinda 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+8,733 vol	8,733
Filed 2023-05-24 13:48 Tx date 2021-06-14	$AUPH Aurinia Pharmaceuticals Inc.	Balakrishnan, Brinda 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2023-05-24 13:47 Tx date 2023-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Balakrishnan, Brinda 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-8,733 vol	0
Filed 2023-05-23 19:01 Tx date 2023-05-22	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	$-73,233.60 -4,818 vol $15.20 each	3,915
Filed 2023-05-23 18:58 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$126,628 +8,733 vol $14.50 each	8,733
Filed 2023-05-23 18:36 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)	Common Shares 57 - Exercise of rights	$126,628 +8,733 vol $14.50 each
Filed 2023-05-23 18:23 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+15,234 vol	141,193
Filed 2023-05-23 18:21 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+9,310 vol	9,310
Filed 2023-05-23 18:16 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$126,628 +8,733 vol $14.50 each
Filed 2023-05-23 18:15 Tx date 2019-06-26	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2023-05-23 18:12 Tx date 2023-05-19	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-8,733 vol	0
Filed 2023-03-07 10:52 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+20,816 vol	76,291
Filed 2023-03-07 10:50 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-20,816 vol	148,834
Filed 2023-03-07 10:49 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+107,202 vol	169,650
Filed 2023-03-07 10:44 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$178,283 +20,000 vol $8.91 each	70,000
Filed 2023-03-07 10:40 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+34,693 vol	62,620
Filed 2023-03-07 10:38 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	-34,693 vol	340,521
Filed 2023-03-07 10:37 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+271,134 vol	375,214
Filed 2023-03-07 10:34 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+3,104 vol	107,401
Filed 2023-03-07 10:32 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+71,330 vol	104,297
Filed 2023-03-07 10:31 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-930,475.20 -104,080 vol $8.94 each	875,567
Filed 2023-03-07 10:27 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+667,407 vol	979,647
Filed 2023-03-07 10:21 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+2,399 vol	32,406
Filed 2023-03-07 10:20 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+23,397 vol	30,007
Filed 2023-03-07 10:17 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-310,155.42 -34,693 vol $8.94 each	298,808
Filed 2023-03-07 10:12 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+229,421 vol	333,501
Filed 2023-03-07 09:48 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+2,194 vol	29,167
Filed 2023-03-07 09:46 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+15,291 vol	26,973
Filed 2023-03-07 09:39 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 57 - Exercise of rights	$-310,155.42 -34,693 vol $8.94 each	274,197
Filed 2023-03-07 09:20 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+204,810 vol	308,890
Filed 2023-03-07 09:14 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+170,188 vol	307,719
Filed 2023-03-07 09:08 Tx date 2023-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Knappertz, Volker 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+191,462 vol	344,274
Filed 2022-11-23 16:05 Tx date 2022-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+1,703 vol	27,927
Filed 2022-11-23 16:04 Tx date 2022-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$46,600 +10,000 vol $4.66 each	26,224
Filed 2022-11-15 08:48 Tx date 2022-11-09	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$25,075 +5,000 vol $5.01 each	5,000
Filed 2022-11-15 08:43 Tx date 2022-07-18	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2022-11-09 16:14 Tx date 2022-11-07	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$154,800 +30,000 vol $5.16 each	55,475
Filed 2022-08-02 10:00 Tx date 2022-08-01	$AUPH Aurinia Pharmaceuticals Inc.	Knappertz, Volker 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+152,812 vol	152,812
Filed 2022-08-02 09:58 Tx date 2022-07-18	$AUPH Aurinia Pharmaceuticals Inc.	Knappertz, Volker 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-08-02 09:58 Tx date 2022-08-01	$AUPH Aurinia Pharmaceuticals Inc.	Knappertz, Volker 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$2,101,376 +256,892 vol $8.18 each	256,892
Filed 2022-08-02 09:51 Tx date 2022-08-01	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+137,531 vol	137,531
Filed 2022-08-02 09:49 Tx date 2022-07-18	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-08-02 09:47 Tx date 2022-08-01	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,891,240 +231,203 vol $8.18 each	231,203
Filed 2022-07-25 10:44 Tx date 2022-07-18	$AUPH Aurinia Pharmaceuticals Inc.	Habig, Scott 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2022-07-25 10:39 Tx date 2022-07-18	$AUPH Aurinia Pharmaceuticals Inc.	Knappertz, Volker 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2022-07-11 13:17 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$36,200 +10,000 vol $3.62 each	40,000
Filed 2022-07-11 13:12 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-47,300 -10,000 vol $4.73 each	170,959
Filed 2022-05-23 11:35 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Walbert, Timothy 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$167,307 +14,612 vol $11.45 each	125,959
Filed 2022-05-23 11:34 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Walbert, Timothy 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+8,733 vol	8,733
Filed 2022-05-23 11:33 Tx date 2020-04-14	$AUPH Aurinia Pharmaceuticals Inc.	Walbert, Timothy 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-23 11:30 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$167,307 +14,612 vol $11.45 each	210,959
Filed 2022-05-23 11:29 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+8,733 vol	8,733
Filed 2022-05-23 11:28 Tx date 2017-05-08	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-23 11:26 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$167,307 +14,612 vol $11.45 each	125,959
Filed 2022-05-23 11:24 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+8,733 vol	8,733
Filed 2022-05-23 11:23 Tx date 2019-11-13	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-23 11:20 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$167,307 +14,612 vol $11.45 each	180,959
Filed 2022-05-23 11:18 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+8,733 vol	8,733
Filed 2022-05-23 11:17 Tx date 2015-05-26	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-23 11:14 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$167,307 +14,612 vol $11.45 each	130,959
Filed 2022-05-23 11:07 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+8,733 vol	8,733
Filed 2022-05-23 11:06 Tx date 2018-02-07	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-23 11:02 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$167,307 +14,612 vol $11.45 each	140,959
Filed 2022-05-23 10:59 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+8,733 vol	8,733
Filed 2022-05-23 10:58 Tx date 2019-04-29	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-23 10:46 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Balakrishnan, Brinda 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$167,307 +14,612 vol $11.45 each	67,903
Filed 2022-05-23 10:40 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Balakrishnan, Brinda 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+8,733 vol	8,733
Filed 2022-05-23 10:38 Tx date 2021-06-14	$AUPH Aurinia Pharmaceuticals Inc.	Balakrishnan, Brinda 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-20 21:25 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+14,612 vol	125,959
Filed 2022-05-20 21:21 Tx date 2022-05-18	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+8,733 vol	8,733
Filed 2022-05-20 21:19 Tx date 2019-06-26	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-03-11 19:31 Tx date 2022-03-09	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$54,985 +5,000 vol $11.00 each	9,400
Filed 2022-03-11 12:05 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$2,138,536 +178,063 vol $12.01 each	621,471
Filed 2022-03-07 11:21 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$2,078,486 +173,063 vol $12.01 each
Filed 2022-03-08 16:42 Tx date 2022-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$54,100 +5,000 vol $10.82 each	50,000
Filed 2022-03-07 22:11 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 57 - Exercise of rights	$-102,085 -8,500 vol $12.01 each	0
Filed 2022-03-07 22:04 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 51 - Exercise of options	$-102,085 -8,500 vol $12.01 each	0
Filed 2022-03-07 17:47 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,654 vol	90,953
Filed 2022-03-07 17:46 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 57 - Exercise of rights	$-102,085 -8,500 vol $12.01 each	0
Filed 2022-03-07 17:44 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 58 - Expiration of rights	-34,000 vol	8,500
Filed 2022-03-07 17:42 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+8,500 vol	11,682
Filed 2022-03-07 17:41 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 57 - Exercise of rights	-8,500 vol	0
Filed 2022-03-07 17:40 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 58 - Expiration of rights	-34,000 vol	8,500
Filed 2022-03-07 17:38 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+5,440 vol	6,610
Filed 2022-03-07 17:37 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 57 - Exercise of rights	$-102,085 -8,500 vol $12.01 each	0
Filed 2022-03-07 17:27 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 58 - Expiration of rights	-34,000 vol	8,500
Filed 2022-03-07 17:22 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,651 vol	25,475
Filed 2022-03-07 17:20 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 57 - Exercise of rights	$-102,085 -8,500 vol $12.01 each	0
Filed 2022-03-07 17:20 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 57 - Exercise of rights	$-102,085 -8,500 vol $12.01 each
Filed 2022-03-07 17:18 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 58 - Expiration of rights	-34,000 vol	8,500
Filed 2022-03-07 17:15 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,651 vol	69,379
Filed 2022-03-07 17:14 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 51 - Exercise of options	$-102,085 -8,500 vol $12.01 each	0
Filed 2022-03-07 17:14 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 51 - Exercise of options	$-102,085 -8,500 vol $12.01 each
Filed 2022-03-07 17:11 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 58 - Expiration of rights	-34,000 vol	8,500
Filed 2022-03-07 17:08 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+19,232 vol	32,967
Filed 2022-03-07 17:07 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 57 - Exercise of rights	$-339,883 -28,300 vol $12.01 each	0
Filed 2022-03-07 17:05 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 58 - Expiration of rights	-113,200 vol	28,300
Filed 2022-03-07 16:57 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+5,448 vol	16,224
Filed 2022-03-07 16:51 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 57 - Exercise of rights	$-102,085 -8,500 vol $12.01 each	0
Filed 2022-03-07 16:47 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 58 - Expiration of rights	-34,000 vol	8,500
Filed 2022-03-07 16:34 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$63,592 +5,295 vol $12.01 each	13,495
Filed 2022-03-07 16:30 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 57 - Exercise of rights	$-102,085 -8,500 vol $12.01 each	0
Filed 2022-03-07 15:50 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+8,500 vol
Filed 2022-03-07 15:50 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+8,500 vol	16,700
Filed 2022-03-07 15:47 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 50 - Grant of options	-8,500 vol	0
Filed 2022-03-07 15:47 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 50 - Grant of options	-8,500 vol
Filed 2022-03-07 15:44 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 58 - Expiration of rights	-34,000 vol	8,500
Filed 2022-03-07 15:37 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+312,240 vol	312,240
Filed 2022-03-07 15:36 Tx date 2019-04-29	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 15:34 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+72,856 vol	72,856
Filed 2022-03-07 15:33 Tx date 2013-09-20	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 15:31 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+104,080 vol	104,080
Filed 2022-03-07 15:21 Tx date 2014-06-16	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 15:18 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+104,080 vol	104,080
Filed 2022-03-07 15:16 Tx date 2020-04-27	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 15:13 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+62,448 vol	62,448
Filed 2022-03-07 15:12 Tx date 2013-09-14	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 15:09 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+62,448 vol	62,448
Filed 2022-03-07 15:07 Tx date 2011-08-23	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 15:04 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+104,080 vol	104,080
Filed 2022-03-07 15:00 Tx date 2019-07-17	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 14:58 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 56 - Grant of rights	+104,080 vol	104,080
Filed 2022-03-07 14:37 Tx date 2020-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Stock Unit 00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 13:01 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+462 vol	3,182
Filed 2022-03-07 12:56 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+170 vol	1,170
Filed 2022-03-07 12:49 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+282 vol	13,735
Filed 2022-03-07 12:42 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	+876 vol	10,776
Filed 2022-03-07 11:32 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$6,415,597 +534,188 vol $12.01 each	3,363,988
Filed 2022-03-07 11:27 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,496,974 +124,644 vol $12.01 each	420,734
Filed 2022-03-07 11:21 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$2,078,486 +173,063 vol $12.01 each	616,471
Filed 2022-03-07 11:13 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$2,138,536 +178,063 vol $12.01 each	631,113
Filed 2022-03-07 11:07 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,283,124 +106,838 vol $12.01 each	217,363
Filed 2022-03-07 11:02 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,283,124 +106,838 vol $12.01 each	560,395
Filed 2022-03-07 10:55 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$2,138,536 +178,063 vol $12.01 each	791,515
Filed 2022-03-07 10:05 Tx date 2022-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$2,138,536 +178,063 vol $12.01 each	850,700
Filed 2022-01-04 17:32 Tx date 2022-01-03	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-14,765.86 -634 vol $23.29 each	3,500
Filed 2022-01-04 17:32 Tx date 2022-01-03	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-888,884.28 -39,366 vol $22.58 each	4,134
Filed 2022-01-04 17:29 Tx date 2022-01-03	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$203,200 +40,000 vol $5.08 each	43,500
Filed 2022-01-04 17:27 Tx date 2022-01-03	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-256,000 -40,000 vol $6.40 each	116,347
Filed 2021-12-16 10:02 Tx date 2021-12-13	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$32,064 +1,600 vol $20.04 each	5,300
Filed 2021-11-12 16:37 Tx date 2021-11-11	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-324,500 -11,000 vol $29.50 each	21,824
Filed 2021-11-12 16:36 Tx date 2021-11-11	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-835,780 -29,000 vol $28.82 each	32,824
Filed 2021-11-12 16:35 Tx date 2021-11-11	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$835,780 +29,000 vol $28.82 each	61,824
Filed 2021-11-12 16:33 Tx date 2021-11-11	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-702,380 -29,000 vol $24.22 each	110,525
Filed 2021-11-12 16:31 Tx date 2021-11-10	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-305,500 -10,000 vol $30.55 each	32,824
Filed 2021-11-12 16:30 Tx date 2021-11-10	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,527,500 -50,000 vol $30.55 each	42,824
Filed 2021-11-12 16:29 Tx date 2021-11-09	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,508,500 -50,000 vol $30.17 each	92,824
Filed 2021-11-12 16:02 Tx date 2021-11-11	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,889,000 -100,000 vol $28.89 each	87,299
Filed 2021-11-12 16:01 Tx date 2021-11-11	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$530,000 +100,000 vol $5.30 each	187,299
Filed 2021-11-12 16:00 Tx date 2021-11-11	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-652,000 -100,000 vol $6.52 each	296,090
Filed 2021-11-12 15:58 Tx date 2021-11-10	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-305,500 -10,000 vol $30.55 each	87,299
Filed 2021-11-12 15:57 Tx date 2021-11-10	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,805,300 -90,000 vol $31.17 each	97,299
Filed 2021-11-12 15:57 Tx date 2021-11-10	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$159,000 +30,000 vol $5.30 each	187,299
Filed 2021-11-12 15:56 Tx date 2021-11-10	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-195,600 -30,000 vol $6.52 each	396,090
Filed 2021-11-12 15:53 Tx date 2021-11-10	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$424,200 +70,000 vol $6.06 each	157,299
Filed 2021-11-12 15:49 Tx date 2021-11-10	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-562,800 -70,000 vol $8.04 each	426,090
Filed 2021-11-12 15:41 Tx date 2021-11-09	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,508,500 -50,000 vol $30.17 each	87,299
Filed 2021-11-04 09:54 Tx date 2021-11-01	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,423,800 -45,000 vol $31.64 each	142,824
Filed 2021-11-04 09:53 Tx date 2021-11-01	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$144,000 +45,000 vol $3.20 each	187,824
Filed 2021-11-04 09:45 Tx date 2021-11-01	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-189,450 -45,000 vol $4.21 each	139,525
Filed 2021-11-04 09:38 Tx date 2021-11-01	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,423,800 -45,000 vol $31.64 each	137,299
Filed 2021-11-04 09:36 Tx date 2021-11-01	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$238,500 +45,000 vol $5.30 each	182,299
Filed 2021-11-04 09:34 Tx date 2021-11-01	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-293,400 -45,000 vol $6.52 each	496,090
Filed 2021-10-27 09:41 Tx date 2021-10-25	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,867,500 -130,000 vol $29.75 each	65,728
Filed 2021-10-27 09:40 Tx date 2021-10-25	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$304,000 +95,000 vol $3.20 each	195,728
Filed 2021-10-27 09:38 Tx date 2021-10-25	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-399,950 -95,000 vol $4.21 each	453,557
Filed 2021-09-23 15:12 Tx date 2021-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,101,750 -87,500 vol $24.02 each	142,824
Filed 2021-09-23 15:10 Tx date 2021-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$183,800 +10,000 vol $18.38 each	230,324
Filed 2021-09-23 15:09 Tx date 2021-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$424,200 +70,000 vol $6.06 each	220,324
Filed 2021-09-23 15:09 Tx date 2021-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$39,750 +7,500 vol $5.30 each	150,324
Filed 2021-09-23 15:08 Tx date 2021-09-20	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-345,600 -16,000 vol $21.60 each	142,824
Filed 2021-09-23 15:07 Tx date 2021-09-20	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-271,375 -12,500 vol $21.71 each	158,824
Filed 2021-09-23 15:05 Tx date 2021-09-20	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$151,050 +28,500 vol $5.30 each	171,324
Filed 2021-09-23 15:03 Tx date 2021-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-242,200 -10,000 vol $24.22 each	184,525
Filed 2021-09-23 15:01 Tx date 2021-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-562,800 -70,000 vol $8.04 each	194,525
Filed 2021-09-23 14:58 Tx date 2021-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-48,900 -7,500 vol $6.52 each	264,525
Filed 2021-09-23 14:56 Tx date 2021-09-20	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-185,820 -28,500 vol $6.52 each	272,025
Filed 2021-09-23 14:43 Tx date 2021-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-126,912.24 -5,364 vol $23.66 each	100,728
Filed 2021-09-23 14:42 Tx date 2021-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-652,620.80 -27,136 vol $24.05 each	106,092
Filed 2021-09-23 14:41 Tx date 2021-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$35,635 +11,136 vol $3.20 each	133,228
Filed 2021-09-23 14:40 Tx date 2021-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$42,080 +16,000 vol $2.63 each	122,092
Filed 2021-09-23 14:38 Tx date 2021-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-46,882.56 -11,136 vol $4.21 each	548,557
Filed 2021-09-23 14:35 Tx date 2021-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-56,000 -16,000 vol $3.50 each	559,693
Filed 2021-09-17 15:48 Tx date 2021-09-14	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-159,300 -30,000 vol $5.31 each	142,824
Filed 2021-09-17 15:47 Tx date 2021-09-14	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-304,220 -14,000 vol $21.73 each	172,824
Filed 2021-09-17 15:45 Tx date 2021-09-14	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$233,639 +44,000 vol $5.31 each	186,824
Filed 2021-09-17 15:44 Tx date 2021-09-14	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-286,880 -44,000 vol $6.52 each	300,525
Filed 2021-09-17 15:39 Tx date 2021-09-14	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-144,000 -45,000 vol $3.20 each	142,824
Filed 2021-09-17 15:38 Tx date 2021-09-14	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$144,000 +45,000 vol $3.20 each	187,824
Filed 2021-09-17 15:37 Tx date 2021-09-14	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-189,450 -45,000 vol $4.21 each	344,525
Filed 2021-09-17 15:34 Tx date 2021-09-14	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-238,950 -45,000 vol $5.31 each	142,824
Filed 2021-09-17 15:33 Tx date 2021-09-14	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$238,949 +45,000 vol $5.31 each	187,824
Filed 2021-09-17 15:30 Tx date 2021-09-14	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-293,400 -45,000 vol $6.52 each	389,525
Filed 2021-09-17 15:24 Tx date 2021-09-13	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-132,750 -25,000 vol $5.31 each	142,824
Filed 2021-09-17 15:22 Tx date 2021-09-13	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$132,750 +25,000 vol $5.31 each	167,824
Filed 2021-09-17 15:18 Tx date 2021-09-13	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-163,000 -25,000 vol $6.52 each	434,525
Filed 2021-09-16 11:51 Tx date 2021-09-10	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,976,000 -150,000 vol $19.84 each	137,299
Filed 2021-09-16 11:49 Tx date 2021-09-10	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$480,000 +150,000 vol $3.20 each	287,299
Filed 2021-09-16 11:45 Tx date 2021-09-13	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-631,500 -150,000 vol $4.21 each	541,090
Filed 2021-09-15 16:06 Tx date 2021-09-10	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-687,375 -32,500 vol $21.15 each	106,092
Filed 2021-09-08 15:47 Tx date 2021-09-07	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-91,500 -5,000 vol $18.30 each	138,592
Filed 2021-09-08 15:37 Tx date 2021-09-07	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-135,750 -7,500 vol $18.10 each	142,824
Filed 2021-08-27 16:21 Tx date 2021-08-26	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-400,725 -22,500 vol $17.81 each	150,324
Filed 2021-08-26 16:26 Tx date 2021-08-25	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-79,250 -5,000 vol $15.85 each	137,299
Filed 2021-08-10 16:17 Tx date 2021-08-09	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-80,050 -5,000 vol $16.01 each	172,824
Filed 2021-08-10 16:05 Tx date 2021-08-09	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-721,350 -45,000 vol $16.03 each	142,299
Filed 2021-07-29 16:27 Tx date 2021-07-28	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-87,073 -5,000 vol $17.41 each	177,824
Filed 2021-06-23 16:37 Tx date 2021-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-85,050 -5,000 vol $17.01 each	182,824
Filed 2021-06-18 11:17 Tx date 2021-06-14	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+31,347 vol	111,347
Filed 2021-06-17 17:13 Tx date 2021-06-14	$AUPH Aurinia Pharmaceuticals Inc.	Walbert, Timothy 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$403,122 +31,347 vol $12.86 each	111,347
Filed 2021-06-17 17:09 Tx date 2021-06-14	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$403,122 +31,347 vol $12.86 each	111,347
Filed 2021-06-17 17:06 Tx date 2021-06-14	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$403,122 +31,347 vol $12.86 each	166,347
Filed 2021-06-17 17:03 Tx date 2021-06-14	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$403,122 +31,347 vol $12.86 each	156,347
Filed 2021-06-17 16:59 Tx date 2021-06-14	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$403,122 +31,347 vol $12.86 each	126,347
Filed 2021-06-17 16:56 Tx date 2021-06-14	$AUPH Aurinia Pharmaceuticals Inc.	Balakrishnan, Brinda 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$685,322 +53,291 vol $12.86 each	53,291
Filed 2021-06-17 16:54 Tx date 2021-06-14	$AUPH Aurinia Pharmaceuticals Inc.	Balakrishnan, Brinda 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2021-06-17 16:50 Tx date 2021-06-14	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$403,122 +31,347 vol $12.86 each	196,347
Filed 2021-05-12 18:48 Tx date 2021-05-12	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Holder: TFSA (RHM) (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$18,040 +1,600 vol $11.28 each	1,600
Filed 2021-05-12 18:48 Tx date 2019-06-26	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Holder: TFSA (RHM) (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-05-12 18:45 Tx date 2021-05-12	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$15,764 +1,400 vol $11.26 each	4,400
Filed 2021-05-12 18:45 Tx date 2021-05-11	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$11,140 +1,000 vol $11.14 each	3,000
Filed 2021-05-12 18:44 Tx date 2021-05-11	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$5,585 +500 vol $11.17 each	2,000
Filed 2021-05-12 17:26 Tx date 2021-05-11	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$99,693 +9,900 vol $10.07 each	9,900
Filed 2021-05-12 17:25 Tx date 2019-07-17	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-05-12 17:23 Tx date 2021-05-11	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$54,888 +5,125 vol $10.71 each	13,453
Filed 2021-05-12 17:18 Tx date 2021-05-11	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$78,200 +20,000 vol $3.91 each	187,824
Filed 2021-05-12 17:18 Tx date 2021-05-11	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-78,200 -20,000 vol $3.91 each	459,525
Filed 2021-05-12 16:28 Tx date 2021-05-11	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$27,389 +2,500 vol $10.96 each	3,700
Filed 2021-05-11 17:27 Tx date 2021-05-11	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$156,400 +40,000 vol $3.91 each	143,592
Filed 2021-05-11 17:26 Tx date 2021-05-11	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-156,400 -40,000 vol $3.91 each	575,693
Filed 2021-05-11 16:55 Tx date 2021-05-11	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$9,740 +1,000 vol $9.74 each	1,000
Filed 2021-03-15 21:52 Tx date 2021-03-11	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-40,000 vol	187,299
Filed 2021-03-15 21:52 Tx date 2021-03-11	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$156,400 +40,000 vol $3.91 each	227,299
Filed 2021-03-15 21:51 Tx date 2021-03-11	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-156,400 -40,000 vol $3.91 each	691,090
Filed 2021-03-09 13:28 Tx date 2021-03-05	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$65,000 +5,000 vol $13.00 each	45,000
Filed 2021-02-01 19:00 Tx date 2021-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Holder: GRAY, ALISON (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$3,172 +150 vol $21.15 each	150
Filed 2021-02-01 18:59 Tx date 2019-11-13	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Holder: GRAY, ALISON (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-02-01 18:59 Tx date 2021-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Holder: GRAY, LINSEY (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$3,172 +150 vol $21.15 each	150
Filed 2021-02-01 18:58 Tx date 2019-11-13	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Holder: GRAY, LINSEY (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-02-01 18:58 Tx date 2021-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Holder: GRAY, MITCHELL R. (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$2,115 +100 vol $21.15 each	100
Filed 2021-02-01 18:57 Tx date 2019-11-13	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Holder: GRAY, MITCHELL R. (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-02-01 18:57 Tx date 2021-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Holder: GRAY, DAVID (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$8,460 +400 vol $21.15 each	400
Filed 2021-02-01 18:56 Tx date 2019-11-13	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Holder: GRAY, DAVID (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-02-01 18:56 Tx date 2021-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$25,380 +1,200 vol $21.15 each	1,200
Filed 2021-02-01 15:21 Tx date 2020-06-01	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Holder: Shelburne Wood Protection (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$21,240 +1,000 vol $21.24 each	1,000
Filed 2021-02-01 15:21 Tx date 2019-11-13	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Holder: Shelburne Wood Protection (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-02-01 15:12 Tx date 2021-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$125,850 +15,000 vol $8.39 each	95,000
Filed 2021-02-01 15:12 Tx date 2021-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$241,199 +30,000 vol $8.04 each	80,000
Filed 2021-02-01 15:11 Tx date 2021-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$346,000 +50,000 vol $6.92 each	50,000
Filed 2021-02-01 15:10 Tx date 2018-02-21	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-02-01 15:10 Tx date 2021-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-125,850 -15,000 vol $8.39 each	30,000
Filed 2021-02-01 15:09 Tx date 2021-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-241,200 -30,000 vol $8.04 each	45,000
Filed 2021-02-01 15:08 Tx date 2021-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-346,000 -50,000 vol $6.92 each	75,000
Filed 2020-06-04 14:24 Tx date 2020-06-01	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$21,240 +1,000 vol $21.24 each
Filed 2021-01-29 12:51 Tx date 2021-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$14,526 +900 vol $16.14 each	2,720
Filed 2020-12-31 14:37 Tx date 2019-01-11	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-82,450 -19,400 vol $4.25 each	368,039
Filed 2020-12-31 14:36 Tx date 2019-01-09	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-170,000 -40,000 vol $4.25 each	387,439
Filed 2020-12-31 14:27 Tx date 2019-12-12	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-92,909.25 -21,861 vol $4.25 each	330,000
Filed 2020-12-31 14:26 Tx date 2019-09-27	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-78,200 -20,000 vol $3.91 each	351,861
Filed 2020-12-31 14:25 Tx date 2019-09-27	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-145,000 -20,000 vol $7.25 each
Filed 2020-12-31 14:25 Tx date 2019-09-26	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-117,180 -21,000 vol $5.58 each
Filed 2020-12-31 14:24 Tx date 2019-09-26	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-89,250 -21,000 vol $4.25 each	371,861
Filed 2020-12-31 14:22 Tx date 2019-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-192,006.50 -45,178 vol $4.25 each	392,861
Filed 2020-12-31 10:32 Tx date 2020-12-31	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$39,600 +10,000 vol $3.96 each	30,000
Filed 2020-12-31 10:32 Tx date 2020-12-31	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-39,600 -10,000 vol $3.96 each	135,000
Filed 2019-12-17 10:19 Tx date 2019-12-12	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$92,909 +21,861 vol $4.25 each
Filed 2019-10-01 14:07 Tx date 2019-09-27	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-145,000 -20,000 vol $7.25 each
Filed 2019-10-01 14:02 Tx date 2019-09-26	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-117,180 -21,000 vol $5.58 each
Filed 2019-10-01 14:00 Tx date 2019-09-27	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$78,200 +20,000 vol $3.91 each
Filed 2019-10-01 13:58 Tx date 2019-09-26	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$89,250 +21,000 vol $4.25 each
Filed 2019-05-02 15:50 Tx date 2019-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$192,006 +45,178 vol $4.25 each
Filed 2020-12-30 16:54 Tx date 2020-12-29	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$30,624 +2,200 vol $13.92 each	8,200
Filed 2020-12-30 16:53 Tx date 2020-12-28	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$28,580 +2,000 vol $14.29 each	6,000
Filed 2020-12-30 16:53 Tx date 2020-12-22	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$10,816 +800 vol $13.52 each	4,000
Filed 2020-12-30 16:52 Tx date 2020-12-22	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$43,232 +3,200 vol $13.51 each	3,200
Filed 2020-12-28 14:28 Tx date 2020-12-21	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,076,603 +82,625 vol $13.03 each	714,003
Filed 2020-12-28 14:19 Tx date 2020-10-23	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+42,500 vol	42,500
Filed 2020-12-28 14:18 Tx date 2013-09-14	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 00 - Opening Balance-Initial SEDI Report
Filed 2020-12-23 19:00 Tx date 2020-12-21	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,882,626 +144,484 vol $13.03 each	443,408
Filed 2020-12-23 18:55 Tx date 2020-12-21	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$2,921,117 +224,184 vol $13.03 each	731,090
Filed 2020-12-23 18:53 Tx date 2020-12-21	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,219,516 +93,593 vol $13.03 each	615,693
Filed 2020-12-23 18:52 Tx date 2020-08-17	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-140,304.05 -31,529 vol $4.45 each	522,100
Filed 2020-12-23 18:34 Tx date 2020-12-21	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$3,087,484 +236,952 vol $13.03 each	613,452
Filed 2020-12-23 18:32 Tx date 2020-12-21	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$4,385,637 +336,580 vol $13.03 each	672,637
Filed 2020-12-23 18:30 Tx date 2020-12-21	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$10,645,822 +817,024 vol $13.03 each	2,829,800
Filed 2020-12-23 18:28 Tx date 2020-12-21	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$3,526,048 +270,610 vol $13.03 each	453,050
Filed 2020-08-20 16:06 Tx date 2020-08-17	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$140,304 +31,529 vol $4.45 each
Filed 2020-12-21 18:59 Tx date 2020-12-21	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$262,076 +20,000 vol $13.10 each	40,000
Filed 2020-11-17 14:31 Tx date 2020-11-16	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$4,005,581 +298,924 vol $13.40 each	298,924
Filed 2020-11-17 14:27 Tx date 2014-06-16	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2020-10-28 11:03 Tx date 2020-10-23	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+42,500 vol	42,500
Filed 2020-10-28 11:03 Tx date 2013-09-20	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 17:20 Tx date 2020-10-23	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+42,500 vol	42,500
Filed 2020-10-26 17:19 Tx date 2019-07-17	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 17:19 Tx date 2020-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$3,063,830 +126,500 vol $24.22 each	376,500
Filed 2020-10-26 17:17 Tx date 2019-08-19	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,962,500 +250,000 vol $7.85 each	250,000
Filed 2020-10-26 17:16 Tx date 2019-07-17	$AUPH Aurinia Pharmaceuticals Inc.	Donley, Matthew 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 15:13 Tx date 2020-10-23	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+141,500 vol	141,500
Filed 2020-10-26 15:12 Tx date 2019-04-29	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 15:07 Tx date 2020-10-23	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+42,500 vol	42,500
Filed 2020-10-26 15:07 Tx date 2020-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 14:58 Tx date 2020-10-23	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+42,500 vol	42,500
Filed 2020-10-26 14:58 Tx date 2011-08-23	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 14:55 Tx date 2020-10-23	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+42,500 vol	42,500
Filed 2020-10-26 14:54 Tx date 2014-06-16	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 14:14 Tx date 2020-10-23	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 56 - Grant of rights	+42,500 vol	42,500
Filed 2020-10-26 14:11 Tx date 2020-04-27	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Rights Performance Award 00 - Opening Balance-Initial SEDI Report
Filed 2020-09-25 18:13 Tx date 2020-09-21	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-731,051.9254 -48,458 vol $15.09 each	6,499,881
Filed 2020-09-25 18:12 Tx date 2020-09-25	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-731,051.9254 -48,458 vol $15.09 each
Filed 2020-09-25 18:09 Tx date 2020-09-25	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-731,051.9254 -48,458 vol $15.09 each
Filed 2020-09-18 18:19 Tx date 2020-09-17	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-727,265.3232 -48,464 vol $15.01 each	6,548,339
Filed 2020-09-18 18:18 Tx date 2020-09-16	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-2,121,956.7516 -140,553 vol $15.10 each	6,596,803
Filed 2020-09-18 18:16 Tx date 2020-09-15	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-320,281.4264 -21,316 vol $15.03 each	6,737,356
Filed 2020-08-20 16:10 Tx date 2020-08-18	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-266,176.40 -14,000 vol $19.01 each	103,592
Filed 2020-08-20 16:08 Tx date 2020-08-17	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$140,304 +31,529 vol $4.45 each	117,592
Filed 2020-08-20 16:06 Tx date 2020-08-17	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$140,304 +31,529 vol $4.45 each	585,158
Filed 2020-07-24 11:25 Tx date 2020-07-22	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-9,844,800 -600,000 vol $16.41 each	6,758,672
Filed 2020-07-11 19:07 Tx date 2020-07-08	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-211,500 -10,000 vol $21.15 each	187,299
Filed 2020-06-26 18:00 Tx date 2020-06-23	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-1,307,581.395 -79,825 vol $16.38 each	7,358,672
Filed 2020-06-16 12:00 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Walbert, Timothy 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$472,500 +30,000 vol $15.75 each	80,000
Filed 2020-06-16 11:57 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$472,500 +30,000 vol $15.75 each	145,000
Filed 2020-06-16 11:55 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$472,500 +30,000 vol $15.75 each	125,000
Filed 2020-06-16 11:53 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$472,500 +30,000 vol $15.75 each	165,000
Filed 2020-06-16 11:50 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$472,500 +30,000 vol $15.75 each	125,000
Filed 2020-06-16 11:47 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$472,500 +30,000 vol $15.75 each	95,000
Filed 2020-06-16 11:41 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+30,000 vol	80,000
Filed 2020-06-16 11:24 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$472,500 +30,000 vol $15.75 each	80,000
Filed 2020-06-03 20:26 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each
Filed 2020-06-03 20:25 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+30,000 vol
Filed 2020-06-03 20:24 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each
Filed 2020-06-03 20:22 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each
Filed 2020-06-03 14:40 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each
Filed 2020-06-03 14:35 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Walbert, Timothy 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each
Filed 2020-06-03 14:31 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each
Filed 2020-06-03 14:27 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each
Filed 2020-06-04 14:24 Tx date 2020-06-01	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$21,240 +1,000 vol $21.24 each	1,000
Filed 2020-06-03 20:26 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each	80,000
Filed 2020-06-03 20:25 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+30,000 vol	80,000
Filed 2020-06-03 20:24 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each	125,000
Filed 2020-06-03 20:22 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each	125,000
Filed 2020-06-03 14:40 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each	95,000
Filed 2020-06-03 14:35 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Walbert, Timothy 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each	80,000
Filed 2020-06-03 14:31 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each	165,000
Filed 2020-06-03 14:27 Tx date 2020-06-02	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$642,300 +30,000 vol $21.41 each	145,000
Filed 2020-05-25 16:02 Tx date 2020-05-19	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$69,822 +16,200 vol $4.31 each	20,000
Filed 2020-05-25 15:59 Tx date 2020-05-19	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-69,822 -16,200 vol $4.31 each	115,000
Filed 2020-05-25 15:48 Tx date 2020-05-21	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,189,000 +50,000 vol $23.78 each	182,440
Filed 2020-05-20 10:57 Tx date 2020-05-13	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-331,934.5191 -18,399 vol $18.04 each	3,354,918
Filed 2020-05-20 10:55 Tx date 2020-05-12	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-697,963.14 -37,575 vol $18.58 each	3,373,317
Filed 2020-05-15 18:20 Tx date 2020-05-11	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-3,627,600 -200,000 vol $18.14 each	7,438,497
Filed 2020-05-11 15:39 Tx date 2020-05-07	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-1,707,010 -100,000 vol $17.07 each	7,638,497
Filed 2020-05-11 15:38 Tx date 2020-05-06	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-1,883,659.2057 -110,151 vol $17.10 each	7,738,497
Filed 2020-05-11 15:36 Tx date 2020-05-05	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-2,814,138.1478 -162,302 vol $17.34 each	7,848,648
Filed 2020-05-11 15:32 Tx date 2019-12-27	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	+430,000 vol	3,410,892
Filed 2020-05-11 15:29 Tx date 2019-12-23	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	+2,980,892 vol	2,980,892
Filed 2020-05-11 15:24 Tx date 2017-03-31	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2020-05-01 19:18 Tx date 2020-04-28	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$3,032,876 +132,440 vol $22.90 each	132,440
Filed 2020-05-01 19:12 Tx date 2020-04-27	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2020-05-01 19:10 Tx date 2020-04-27	$AUPH Aurinia Pharmaceuticals Inc.	Miller, Joseph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2020-04-21 17:37 Tx date 2020-04-14	$AUPH Aurinia Pharmaceuticals Inc.	Walbert, Timothy 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$1,070,500 +50,000 vol $21.41 each	50,000
Filed 2020-04-21 17:32 Tx date 2020-04-14	$AUPH Aurinia Pharmaceuticals Inc.	Walbert, Timothy 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2020-04-21 17:30 Tx date 2020-04-14	$AUPH Aurinia Pharmaceuticals Inc.	Walbert, Timothy 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2020-04-11 12:46 Tx date 2020-04-09	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-86,279.17 -4,100 vol $21.04 each	197,299
Filed 2020-04-10 01:44 Tx date 2020-04-07	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-19,413 -900 vol $21.57 each	201,399
Filed 2020-04-10 01:42 Tx date 2020-04-06	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-316,617 -15,000 vol $21.11 each	202,299
Filed 2020-03-17 17:46 Tx date 2020-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2020-03-17 17:45 Tx date 2020-03-10	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$6,761,466 +336,057 vol $20.12 each	336,057
Filed 2020-03-17 17:43 Tx date 2020-03-02	$AUPH Aurinia Pharmaceuticals Inc.	Colao, Massimiliano 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2020-03-14 19:08 Tx date 2020-03-10	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,275,307 -60,700 vol $21.01 each	217,299
Filed 2020-02-15 09:25 Tx date 2020-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$947,002 +39,100 vol $24.22 each	260,906
Filed 2020-02-06 19:10 Tx date 2020-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,692,978 +69,900 vol $24.22 each	506,906
Filed 2020-02-06 17:33 Tx date 2020-02-05	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$10,645,493 +412,776 vol $25.79 each	2,012,776
Filed 2020-02-05 14:53 Tx date 2020-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,620,318 +66,900 vol $24.22 each	631,378
Filed 2020-02-05 13:39 Tx date 2020-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Eglite, Erik 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,181,936 +48,800 vol $24.22 each	566,300
Filed 2020-02-05 13:21 Tx date 2020-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,479,842 +61,100 vol $24.22 each	553,629
Filed 2020-02-04 18:09 Tx date 2020-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,688,134 +69,700 vol $24.22 each	598,037
Filed 2020-01-31 20:33 Tx date 2020-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,170,352.88 -63,194 vol $18.52 each	4,000
Filed 2020-01-31 20:31 Tx date 2020-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$266,046 +63,194 vol $4.21 each	67,194
Filed 2020-01-31 20:29 Tx date 2020-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-266,046.74 -63,194 vol $4.21 each	221,806
Filed 2020-01-22 15:05 Tx date 2020-01-22	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$9,408 +500 vol $18.82 each	1,500
Filed 2020-01-06 08:21 Tx date 2020-01-02	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,050,500 -50,000 vol $21.01 each	4,000
Filed 2020-01-06 08:21 Tx date 2020-01-02	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$183,000 +50,000 vol $3.66 each	54,000
Filed 2020-01-06 08:18 Tx date 2020-01-02	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-183,000 -50,000 vol $3.66 each	285,000
Filed 2020-01-05 20:37 Tx date 2020-01-02	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-82,860 -3,000 vol $27.62 each	70,891
Filed 2019-12-20 19:11 Tx date 2019-12-19	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$9,298 +500 vol $18.60 each	1,000
Filed 2019-12-20 19:10 Tx date 2019-12-19	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$9,353 +500 vol $18.71 each	500
Filed 2019-12-20 19:10 Tx date 2019-06-26	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-12-20 18:38 Tx date 2019-12-17	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,325,800 -70,000 vol $18.94 each	86,063
Filed 2019-12-20 18:36 Tx date 2019-12-17	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$425,034 +100,008 vol $4.25 each	156,063
Filed 2019-12-20 18:35 Tx date 2019-12-17	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-100,008 vol	492,529
Filed 2019-12-17 17:54 Tx date 2019-12-16	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-120,400 -5,000 vol $24.08 each	73,891
Filed 2019-12-17 17:53 Tx date 2019-12-13	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,362,000 -75,000 vol $18.16 each	78,891
Filed 2019-12-17 17:52 Tx date 2019-12-12	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-122,750 -5,000 vol $24.55 each	16,452
Filed 2019-12-17 17:49 Tx date 2019-12-13	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$584,115 +137,439 vol $4.25 each	153,891
Filed 2019-12-17 17:46 Tx date 2019-12-13	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-137,439 vol	528,337
Filed 2019-12-17 10:24 Tx date 2019-12-12	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	+20,000 vol	167,824
Filed 2019-12-17 10:23 Tx date 2019-12-12	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	+20,000 vol
Filed 2019-12-17 10:21 Tx date 2019-12-12	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	+20,000 vol
Filed 2019-12-17 10:19 Tx date 2019-12-12	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$92,909 +21,861 vol $4.25 each	564,478
Filed 2019-12-16 21:47 Tx date 2019-12-11	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-3,625,680 -200,000 vol $18.13 each	8,010,950
Filed 2019-12-16 18:18 Tx date 2019-12-12	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-483,040 -20,000 vol $24.15 each	277,999
Filed 2019-12-16 14:41 Tx date 2019-12-13	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,253,340.27 -68,601 vol $18.27 each	4,000
Filed 2019-12-16 14:40 Tx date 2019-12-13	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$251,079 +68,601 vol $3.66 each	72,601
Filed 2019-12-16 14:39 Tx date 2019-12-13	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-251,079.66 -68,601 vol $3.66 each	335,000
Filed 2019-12-16 14:13 Tx date 2019-12-12	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-202,290 -11,000 vol $18.39 each	4,000
Filed 2019-12-11 11:05 Tx date 2019-09-06	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Direct Ownership	Total Return Swap 70 - Acquisition or disposition (writing) of third party derivative	+1 vol	1
Filed 2019-12-11 11:02 Tx date 2017-03-31	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Total Return Swap 00 - Opening Balance-Initial SEDI Report		1
Filed 2019-12-09 17:10 Tx date 2019-12-09	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-12,436,240 -800,000 vol $15.55 each	8,210,950
Filed 2019-12-09 17:08 Tx date 2019-12-06	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-16,874,000 -1,100,000 vol $15.34 each	9,010,950
Filed 2019-12-09 17:06 Tx date 2019-12-05	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-9,065,831.58 -541,567 vol $16.74 each	10,110,950
Filed 2019-12-09 17:05 Tx date 2019-11-27	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-358,000 -50,000 vol $7.16 each	10,652,517
Filed 2019-12-09 15:35 Tx date 2017-03-31	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Direct Ownership	Total Return Swap 00 - Opening Balance-Initial SEDI Report
Filed 2019-11-26 19:46 Tx date 2019-11-26	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-1,377,360 -200,000 vol $6.89 each	10,702,517
Filed 2019-11-26 19:44 Tx date 2019-11-25	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-612,740 -100,000 vol $6.13 each	10,902,517
Filed 2019-11-26 19:38 Tx date 2019-11-22	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-24,519.60 -3,892 vol $6.30 each	11,002,517
Filed 2019-11-26 19:36 Tx date 2019-11-21	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-615,210 -100,000 vol $6.15 each	11,006,409
Filed 2019-11-21 18:26 Tx date 2019-11-19	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$379,500 +50,000 vol $7.59 each	50,000
Filed 2019-11-21 18:19 Tx date 2019-11-13	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2019-11-21 18:17 Tx date 2019-11-13	$AUPH Aurinia Pharmaceuticals Inc.	Leversage, Jill Diane 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-10-21 13:27 Tx date 2019-10-16	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$49,600 +10,000 vol $4.96 each	20,000
Filed 2019-10-17 12:18 Tx date 2019-10-11	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 90 - Change in the nature of ownership	-196,200 vol	147,824
Filed 2019-10-15 16:34 Tx date 2019-10-15	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$38,308 +8,328 vol $4.60 each	8,328
Filed 2019-10-15 16:30 Tx date 2019-10-15	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$9,510 +2,000 vol $4.75 each	3,500
Filed 2019-10-15 16:29 Tx date 2019-10-11	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,803 +1,500 vol $3.87 each	1,500
Filed 2019-10-15 16:28 Tx date 2018-02-07	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-10-14 17:11 Tx date 2019-10-14	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$19,350 +5,000 vol $3.87 each	15,000
Filed 2019-10-10 23:42 Tx date 2019-10-10	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$21,204 +3,800 vol $5.58 each	344,024
Filed 2019-10-10 13:46 Tx date 2019-10-10	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$8,506 +2,000 vol $4.25 each	2,000
Filed 2019-10-02 11:48 Tx date 2019-09-30	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$16,169 +3,000 vol $5.39 each	10,000
Filed 2019-10-01 14:07 Tx date 2019-09-27	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-145,000 -20,000 vol $7.25 each	542,617
Filed 2019-10-01 14:02 Tx date 2019-09-26	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-117,180 -21,000 vol $5.58 each	542,617
Filed 2019-10-01 14:00 Tx date 2019-09-27	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$78,200 +20,000 vol $3.91 each	562,617
Filed 2019-10-01 13:58 Tx date 2019-09-26	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$89,250 +21,000 vol $4.25 each	563,617
Filed 2019-09-26 10:58 Tx date 2019-09-26	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$7,812 +1,050 vol $7.44 each	1,820
Filed 2019-07-09 18:43 Tx date 2019-07-08	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$16,377 +3,800 vol $4.31 each	3,800
Filed 2019-07-09 18:42 Tx date 2015-05-26	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-07-09 18:41 Tx date 2019-07-08	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-3,800 vol	131,200
Filed 2019-07-08 19:12 Tx date 2019-07-08	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$63,201 +10,000 vol $6.32 each	10,000
Filed 2019-07-08 19:10 Tx date 2017-05-08	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-07-05 15:18 Tx date 2019-07-03	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	50,000
Filed 2019-07-05 13:12 Tx date 2019-07-03	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$125,850 +15,000 vol $8.39 each	135,000
Filed 2019-07-05 13:02 Tx date 2019-07-03	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$125,850 +15,000 vol $8.39 each	65,000
Filed 2019-07-05 12:46 Tx date 2019-07-03	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$125,850 +15,000 vol $8.39 each	95,000
Filed 2019-07-05 12:37 Tx date 2019-07-03	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$125,850 +15,000 vol $8.39 each	135,000
Filed 2019-07-05 12:33 Tx date 2019-07-03	$AUPH Aurinia Pharmaceuticals Inc.	Lee, Hyuek Joon 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$125,850 +15,000 vol $8.39 each	135,000
Filed 2019-07-05 12:26 Tx date 2019-07-03	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$125,850 +15,000 vol $8.39 each	95,000
Filed 2019-07-03 19:20 Tx date 2019-07-03	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+15,000 vol
Filed 2019-07-03 19:20 Tx date 2019-07-03	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+15,000 vol	15,000
Filed 2019-07-03 19:14 Tx date 2019-06-26	$AUPH Aurinia Pharmaceuticals Inc.	MacKay-Dunn, R. Hector 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2019-07-03 12:56 Tx date 2019-07-01	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-9,772.97 -1,483 vol $6.59 each	0
Filed 2019-07-01 17:56 Tx date 2019-07-01	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$13,200 +2,000 vol $6.60 each	7,000
Filed 2019-05-06 12:40 Tx date 2019-04-29	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$84,500 +10,000 vol $8.45 each	120,000
Filed 2019-05-03 20:07 Tx date 2019-04-29	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$422,499 +50,000 vol $8.45 each	50,000
Filed 2019-05-03 20:02 Tx date 2019-04-29	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2019-05-03 20:00 Tx date 2019-04-29	$AUPH Aurinia Pharmaceuticals Inc.	BILLEN, DANIEL 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		20,000
Filed 2019-05-03 19:46 Tx date 2019-04-29	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$13,519,999 +1,600,000 vol $8.45 each	1,600,000
Filed 2019-05-03 19:39 Tx date 2019-04-29	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2019-05-03 19:36 Tx date 2019-04-29	$AUPH Aurinia Pharmaceuticals Inc.	GREENLEAF, PETER 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-05-02 15:59 Tx date 2018-12-18	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-3,499 vol	435,200
Filed 2019-05-02 15:58 Tx date 2018-12-13	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	$7,498 +3,499 vol $2.14 each
Filed 2019-05-02 15:54 Tx date 2019-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-45,178 vol	340,224
Filed 2019-05-02 15:50 Tx date 2019-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$192,006 +45,178 vol $4.25 each	542,617
Filed 2018-12-13 19:37 Tx date 2018-12-13	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	$7,498 +3,499 vol $2.14 each
Filed 2019-04-26 18:49 Tx date 2019-04-25	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-293,285.452 -34,733 vol $8.44 each	253,266
Filed 2019-04-26 18:48 Tx date 2019-04-23	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-85,279 -10,000 vol $8.53 each	287,999
Filed 2019-04-26 18:45 Tx date 2019-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$190,115 +44,733 vol $4.25 each	297,999
Filed 2019-04-26 18:42 Tx date 2019-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-190,115.25 -44,733 vol $4.25 each	437,006
Filed 2019-04-11 12:39 Tx date 2017-03-31	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN Steel Co., Ltd. (Control or Direction)	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2019-04-11 12:38 Tx date 2017-03-31	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN Steel Co., Ltd. (Control or Direction)	Common Shares 11 - Acquisition or disposition carried out privately	+1,621,271 vol	1,621,271
Filed 2019-04-11 12:37 Tx date 2017-03-31	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN Steel Co., Ltd. (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-04-11 12:17 Tx date 2018-02-14	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 54 - Exercise of warrants	$468,674 +145,533 vol $3.22 each	10,513,189
Filed 2019-04-11 12:16 Tx date 2018-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 54 - Exercise of warrants	$1,483,050 +593,220 vol $2.50 each	11,106,409
Filed 2019-04-11 12:15 Tx date 2017-03-31	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 11 - Acquisition or disposition carried out privately	-1,621,271 vol	10,367,656
Filed 2019-04-11 12:14 Tx date 2017-03-31	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 11 - Acquisition or disposition carried out privately	-811,111 vol	11,988,927
Filed 2019-04-11 12:13 Tx date 2017-03-31	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		12,800,038
Filed 2019-04-11 12:12 Tx date 2019-02-14	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Warrants 54 - Exercise of warrants	-145,533 vol	666,666
Filed 2019-04-11 12:11 Tx date 2018-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Warrants 54 - Exercise of warrants	-593,220 vol	812,199
Filed 2019-04-11 12:06 Tx date 2017-03-31	$AUPH Aurinia Pharmaceuticals Inc.	Huh, Chin Kyu 3 - 10% Security Holder of Issuer Holder: ILJIN SNT Co., Ltd. (Control or Direction)	Warrants 00 - Opening Balance-Initial SEDI Report		1,405,419
Filed 2019-04-05 19:32 Tx date 2019-04-03	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-90,864 -10,000 vol $9.09 each	297,999
Filed 2019-04-03 12:16 Tx date 2019-04-01	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-301,500 -45,000 vol $6.70 each	5,000
Filed 2019-04-03 12:15 Tx date 2019-04-01	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$164,700 +45,000 vol $3.66 each	50,000
Filed 2019-04-03 12:13 Tx date 2019-04-01	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-164,700 -45,000 vol $3.66 each	403,601
Filed 2019-03-04 Tx date 2019-03-01	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-609,280 -68,000 vol $8.96 each	231,399
Filed 2019-03-04 Tx date 2019-03-01	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-436,475 -102,700 vol $4.25 each	481,739
Filed 2019-03-04 Tx date 2019-02-27	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-449,952 -48,000 vol $9.37 each	334,099
Filed 2019-03-04 Tx date 2019-02-27	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-440,578 -47,000 vol $9.37 each
Filed 2019-03-04 Tx date 2019-02-28	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-311,977.29 -34,700 vol $8.99 each	299,399
Filed 2019-03-04 Tx date 2019-03-04	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-227,826.90 -26,100 vol $8.73 each	307,999
Filed 2019-03-04 Tx date 2019-03-01	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$436,475 +102,700 vol $4.25 each	334,099
Filed 2019-03-03 Tx date 2019-02-27	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-440,578 -47,000 vol $9.37 each	335,099
Filed 2019-02-20 Tx date 2019-02-12	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-33,680 -8,000 vol $4.21 each	350,000
Filed 2019-02-20 Tx date 2019-02-15	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$32,599 +5,000 vol $6.52 each	355,000
Filed 2019-02-20 Tx date 2019-02-12	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$33,680 +8,000 vol $4.21 each	358,000
Filed 2019-02-20 Tx date 2019-02-15	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-32,600 -5,000 vol $6.52 each	350,000
Filed 2019-02-11 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Randall, Lorin Jeffry 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$241,199 +30,000 vol $8.04 each	110,000
Filed 2019-02-08 Tx date 2019-02-04	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-87,175 -10,000 vol $8.72 each	382,099
Filed 2019-02-02 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$562,799 +70,000 vol $8.04 each	584,439
Filed 2019-02-02 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$703,499 +87,500 vol $8.04 each	295,695
Filed 2019-02-01 Tx date 2019-02-01	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$562,799 +70,000 vol $8.04 each	497,439
Filed 2019-02-01 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Rovinski, Benjamin 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$241,199 +30,000 vol $8.04 each	130,000
Filed 2019-02-01 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$562,799 +70,000 vol $8.04 each	665,776
Filed 2019-02-01 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Eglite, Erik 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$703,499 +87,500 vol $8.04 each	517,500
Filed 2019-02-01 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$241,199 +30,000 vol $8.04 each	80,000
Filed 2019-02-01 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$562,799 +70,000 vol $8.04 each	448,601
Filed 2019-02-01 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$241,199 +30,000 vol $8.04 each	120,000
Filed 2019-02-01 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$241,199 +30,000 vol $8.04 each	110,000
Filed 2019-02-01 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Lee, Hyuek Joon 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$241,199 +30,000 vol $8.04 each	120,000
Filed 2019-02-01 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$241,199 +30,000 vol $8.04 each	80,000
Filed 2019-02-01 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$562,799 +70,000 vol $8.04 each	592,537
Filed 2019-01-31 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-16,600 -2,000 vol $8.30 each	392,099
Filed 2019-01-31 Tx date 2019-01-28	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-64,584 -8,000 vol $8.07 each	394,099
Filed 2019-01-29 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Holder: Michelle Lynn Glickman (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$25,110 +3,100 vol $8.10 each	113,789
Filed 2019-01-29 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$29,970 +3,700 vol $8.10 each	1,021,206
Filed 2019-01-29 Tx date 2019-01-29	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Holder: Michelle Lynn Glickman (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$9,720 +1,200 vol $8.10 each	110,689
Filed 2019-01-13 Tx date 2019-01-09	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-33,680 -8,000 vol $4.21 each	350,000
Filed 2019-01-13 Tx date 2019-01-09	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$33,680 +8,000 vol $4.21 each	358,000
Filed 2019-01-13 Tx date 2019-01-08	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-65,200 -10,000 vol $6.52 each	350,000
Filed 2019-01-13 Tx date 2019-01-08	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$65,199 +10,000 vol $6.52 each	360,000
Filed 2019-01-13 Tx date 2019-01-08	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-50,000 -12,500 vol $4.00 each	350,000
Filed 2019-01-13 Tx date 2019-01-08	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$50,000 +12,500 vol $4.00 each	362,500
Filed 2019-01-11 Tx date 2019-01-09	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-164,952 -17,400 vol $9.48 each	388,901
Filed 2019-01-11 Tx date 2019-01-10	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-19,720 -2,000 vol $9.86 each	388,901
Filed 2019-01-11 Tx date 2019-01-10	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$8,500 +2,000 vol $4.25 each	390,901
Filed 2019-01-11 Tx date 2019-01-09	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-72,200 -7,600 vol $9.50 each	388,901
Filed 2019-01-11 Tx date 2019-01-07	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-379,200 -40,000 vol $9.48 each	396,501
Filed 2019-01-11 Tx date 2019-01-07	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$170,000 +40,000 vol $4.25 each	436,501
Filed 2019-01-11 Tx date 2019-01-07	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-162,177.14 -17,198 vol $9.43 each	396,501
Filed 2019-01-11 Tx date 2019-01-09	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$73,950 +17,400 vol $4.25 each	406,301
Filed 2019-01-07 Tx date 2019-01-02	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-233,000 -25,000 vol $9.32 each	413,699
Filed 2019-01-03 Tx date 2018-12-28	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,456.40 -220 vol $6.62 each	9,180
Filed 2018-12-27 Tx date 2018-12-24	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-26,219.90 -3,500 vol $7.49 each	402,099
Filed 2018-12-20 Tx date 2018-12-14	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 54 - Exercise of warrants	$7,490 +3,500 vol $2.14 each	405,599
Filed 2018-12-20 Tx date 2018-12-14	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	-3,500 vol	0
Filed 2018-12-20 Tx date 2018-12-14	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Warrants 37 - Stock split or consolidation	-171,477 vol	3,500
Filed 2018-12-18 Tx date 2018-12-18	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$7,650 +1,000 vol $7.65 each	21,452
Filed 2018-12-14 Tx date 2018-12-10	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Holder: Michelle Lynn Glickman (Indirect Ownership)	Warrants 54 - Exercise of warrants	$-7,499.80 -3,500 vol $2.14 each	0
Filed 2018-12-14 Tx date 2018-12-10	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Holder: Michelle Lynn Glickman (Indirect Ownership)	Common Shares 54 - Exercise of warrants	$7,499 +3,500 vol $2.14 each	109,489
Filed 2018-12-14 Tx date 2013-09-20	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Holder: Michelle Lynn Glickman (Indirect Ownership)	Warrants 00 - Opening Balance-Initial SEDI Report		3,500
Filed 2018-12-13 Tx date 2018-12-13	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	$7,498 +3,499 vol $2.14 each	3,500
Filed 2018-12-13 Tx date 2018-12-13	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	$-7,498.357 -3,499 vol $2.14 each	1
Filed 2018-12-13 Tx date 2018-12-07	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-57,460 -6,800 vol $8.45 each	20,452
Filed 2018-12-13 Tx date 2018-12-07	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-12,600 -2,000 vol $6.30 each	27,252
Filed 2018-12-13 Tx date 2018-12-07	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-10,000 vol	595,776
Filed 2018-12-13 Tx date 2018-12-07	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$42,500 +10,000 vol $4.25 each	29,252
Filed 2018-12-10 Tx date 2018-12-06	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-305,320.8299 -48,611 vol $6.28 each	1,483
Filed 2018-12-10 Tx date 2018-12-06	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$40,344 +9,583 vol $4.21 each	11,066
Filed 2018-12-10 Tx date 2018-12-06	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-48,611 vol	225,889
Filed 2018-12-10 Tx date 2018-12-06	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$32,038 +8,111 vol $3.95 each	9,594
Filed 2018-12-10 Tx date 2018-12-06	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$316,943 +48,611 vol $6.52 each	50,094
Filed 2018-12-10 Tx date 2018-12-06	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$60,189 +9,583 vol $6.28 each
Filed 2018-12-10 Tx date 2018-12-07	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-124,200 -20,000 vol $6.21 each	5,000
Filed 2018-12-10 Tx date 2018-12-06	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-50,944.3799 -8,111 vol $6.28 each	1,483
Filed 2018-12-10 Tx date 2018-12-06	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-9,583 vol	208,195
Filed 2018-12-10 Tx date 2018-12-07	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-73,200 -20,000 vol $3.66 each	378,601
Filed 2018-12-10 Tx date 2018-12-06	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-8,111 vol	217,778
Filed 2018-12-10 Tx date 2018-12-06	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-60,189.8647 -9,583 vol $6.28 each	1,483
Filed 2018-12-10 Tx date 2018-12-07	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-73,200 -20,000 vol $3.66 each
Filed 2018-12-10 Tx date 2018-12-07	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$73,200 +20,000 vol $3.66 each	25,000
Filed 2018-11-17 Tx date 2018-11-13	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-100,805.76 -14,400 vol $7.00 each	424,299
Filed 2018-11-17 Tx date 2018-11-15	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-154,982.64 -22,200 vol $6.98 each	402,099
Filed 2018-10-15 Tx date 2018-10-11	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Rashieda Gluck I.R.A. (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-3,402 -600 vol $5.67 each	0
Filed 2018-10-15 Tx date 2018-10-11	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Triskel Health LLC (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-25,695 -4,500 vol $5.71 each	0
Filed 2018-10-15 Tx date 2018-10-11	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Franklin T Gluck I.R.A. (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-5,690 -1,000 vol $5.69 each	0
Filed 2018-06-20 Tx date 2018-06-18	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Triskel Health LLC (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$4,172 +700 vol $5.96 each	4,500
Filed 2018-06-12 Tx date 2016-01-04	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Franklin T Gluck I.R.A. (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report		1,000
Filed 2018-06-12 Tx date 2018-06-07	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Warrants 11 - Acquisition or disposition carried out privately	-1,483 vol	0
Filed 2018-06-12 Tx date 2018-06-07	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Triskel Health LLC (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$21,660 +3,800 vol $5.70 each	3,800
Filed 2018-06-12 Tx date 2016-01-04	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Rashieda Gluck I.R.A. (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report		600
Filed 2018-06-12 Tx date 2018-06-07	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	$4,107 +1,483 vol $2.77 each	1,483
Filed 2018-06-07 Tx date 2018-05-29	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 54 - Exercise of warrants	$4,107 +1,483 vol $2.77 each	56,055
Filed 2018-06-07 Tx date 2018-05-30	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 54 - Exercise of warrants	$4,107 +1,483 vol $2.77 each	19,252
Filed 2018-06-07 Tx date 2018-05-29	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	-1,483 vol	0
Filed 2018-06-07 Tx date 2018-05-30	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	-1,483 vol	0
Filed 2018-05-30 Tx date 2018-05-25	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	$-222,222.50 -88,889 vol $2.50 each	74,152
Filed 2018-05-30 Tx date 2018-05-25	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	$-205,401.04 -74,152 vol $2.77 each	0
Filed 2018-05-30 Tx date 2018-05-25	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Direct Ownership	Common Shares 54 - Exercise of warrants	$205,403 +74,153 vol $2.77 each	1,017,506
Filed 2018-05-30 Tx date 2018-05-23	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Direct Ownership	Common Shares 54 - Exercise of warrants	$205,403 +74,153 vol $2.77 each
Filed 2018-05-30 Tx date 2018-05-25	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Holder: Michelle Lynn Glickman (Control or Direction)	Common Shares 54 - Exercise of warrants	$222,222 +88,889 vol $2.50 each	105,989
Filed 2018-05-21 Tx date 2018-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$90,850 +23,000 vol $3.95 each	88,000
Filed 2018-05-21 Tx date 2018-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-22,500 vol	274,500
Filed 2018-05-21 Tx date 2018-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-23,000 vol	297,000
Filed 2018-05-21 Tx date 2018-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-40,000 vol	320,000
Filed 2018-05-21 Tx date 2018-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-129,750 -25,000 vol $5.19 each	360,000
Filed 2018-05-21 Tx date 2018-05-21	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-56,525.40 -9,300 vol $6.08 each	0
Filed 2018-05-21 Tx date 2018-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-616,308 -101,200 vol $6.09 each	9,300
Filed 2018-05-21 Tx date 2018-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$94,725 +22,500 vol $4.21 each	110,500
Filed 2018-05-21 Tx date 2018-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$135,600 +40,000 vol $3.39 each	65,000
Filed 2018-05-21 Tx date 2018-05-18	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$129,750 +25,000 vol $5.19 each	25,000
Filed 2018-05-21 Tx date 2018-03-27	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-23,850 -4,500 vol $5.30 each	0
Filed 2018-05-21 Tx date 2018-03-27	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Triskel Health LLC (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-5,290 -1,000 vol $5.29 each	0
Filed 2018-03-28 Tx date 2018-03-21	$AUPH Aurinia Pharmaceuticals Inc.	Demers, Ronald Victor 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,059,000 +150,000 vol $7.06 each
Filed 2018-03-28 Tx date 2018-03-21	$AUPH Aurinia Pharmaceuticals Inc.	Demers, Ronald Victor 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,059,000 +150,000 vol $7.06 each	150,000
Filed 2018-03-28 Tx date 2018-03-21	$AUPH Aurinia Pharmaceuticals Inc.	Demers, Ronald Victor 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2018-03-02 Tx date 2018-02-22	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$346,000 +50,000 vol $6.92 each	50,000
Filed 2018-03-02 Tx date 2018-02-21	$AUPH Aurinia Pharmaceuticals Inc.	Hayden, Michael Reuben 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2018-02-14 Tx date 2018-02-07	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2018-02-14 Tx date 2018-02-09	$AUPH Aurinia Pharmaceuticals Inc.	Hagan, Joseph Patrick 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$320,000 +50,000 vol $6.40 each	50,000
Filed 2018-02-13 Tx date 2018-02-01	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,467,000 +225,000 vol $6.52 each	522,537
Filed 2018-02-09 Tx date 2018-02-05	$AUPH Aurinia Pharmaceuticals Inc.	Lee, Hyuek Joon 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$192,600 +30,000 vol $6.42 each	90,000
Filed 2018-02-09 Tx date 2018-02-05	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$192,600 +30,000 vol $6.42 each	80,000
Filed 2018-02-09 Tx date 2018-02-05	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$192,600 +30,000 vol $6.42 each	90,000
Filed 2018-02-07 Tx date 2018-02-01	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$977,999 +150,000 vol $6.52 each	398,601
Filed 2018-02-07 Tx date 2018-02-05	$AUPH Aurinia Pharmaceuticals Inc.	Randall, Lorin Jeffry 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$192,600 +30,000 vol $6.42 each	80,000
Filed 2018-02-07 Tx date 2018-02-01	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,141,000 +175,000 vol $6.52 each	385,000
Filed 2018-02-06 Tx date 2018-02-05	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$2,568,000 +400,000 vol $6.42 each	1,670,000
Filed 2018-02-06 Tx date 2018-02-01	$AUPH Aurinia Pharmaceuticals Inc.	Eglite, Erik 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$977,999 +150,000 vol $6.52 each	430,000
Filed 2018-02-06 Tx date 2018-02-01	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,304,000 +200,000 vol $6.52 each	350,000
Filed 2018-02-06 Tx date 2018-02-01	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$977,999 +150,000 vol $6.52 each	605,776
Filed 2018-02-06 Tx date 2018-02-05	$AUPH Aurinia Pharmaceuticals Inc.	Rovinski, Benjamin 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$192,600 +30,000 vol $6.42 each	100,000
Filed 2018-02-06 Tx date 2018-02-01	$AUPH Aurinia Pharmaceuticals Inc.	Mandt, Lawrence Dean 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$488,999 +75,000 vol $6.52 each	140,877
Filed 2018-02-04 Tx date 2018-02-01	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,141,000 +175,000 vol $6.52 each	514,439
Filed 2018-02-03 Tx date 2018-01-30	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Triskel Health LLC (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$2,760 +500 vol $5.52 each	500
Filed 2018-02-03 Tx date 2018-02-01	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$977,999 +150,000 vol $6.52 each	427,439
Filed 2018-02-03 Tx date 2018-01-31	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Triskel Health LLC (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$2,640 +500 vol $5.28 each	1,000
Filed 2017-12-15 Tx date 2017-12-15	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,172 +250 vol $4.69 each	9,400
Filed 2017-12-04 Tx date 2017-11-20	$AUPH Aurinia Pharmaceuticals Inc.	Eglite, Erik 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$19,456 +3,800 vol $5.12 each	3,800
Filed 2017-12-04 Tx date 2017-07-03	$AUPH Aurinia Pharmaceuticals Inc.	Eglite, Erik 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-11-29 Tx date 2017-11-29	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,351 +263 vol $5.14 each	4,500
Filed 2017-11-17 Tx date 2017-11-17	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$25,857 +3,900 vol $6.63 each	943,353
Filed 2017-10-25 Tx date 2017-10-24	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$9,952 +1,750 vol $5.69 each	9,150
Filed 2017-10-24 Tx date 2017-10-24	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$29,100 +5,000 vol $5.82 each	5,000
Filed 2017-07-21 Tx date 2017-07-18	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-14,160 -2,000 vol $7.08 each	4,237
Filed 2017-07-19 Tx date 2017-03-31	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,735,232.719 -246,587 vol $7.04 each
Filed 2017-07-19 Tx date 2017-03-29	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,460,923.74 -602,014 vol $7.41 each	4,855,508
Filed 2017-07-19 Tx date 2017-03-31	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,735,232.719 -246,587 vol $7.04 each	4,608,921
Filed 2017-07-19 Tx date 2017-03-31	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,934,089.41 -540,026 vol $7.29 each	4,068,895
Filed 2017-07-19 Tx date 2017-04-03	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,227,495 -173,375 vol $7.08 each	3,895,520
Filed 2017-07-19 Tx date 2017-04-04	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-656,672.87 -94,225 vol $6.97 each	3,801,295
Filed 2017-07-19 Tx date 2017-04-05	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,805,083.4958 -260,903 vol $6.92 each	3,540,392
Filed 2017-07-19 Tx date 2017-04-06	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,265,365.90 -193,000 vol $6.56 each	3,347,392
Filed 2017-07-19 Tx date 2017-04-11	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-3,217,351.6627 -445,487 vol $7.22 each	2,901,905
Filed 2017-07-19 Tx date 2017-04-12	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-169,251.1184 -24,092 vol $7.03 each	2,877,813
Filed 2017-07-19 Tx date 2017-04-13	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-733,735.604 -106,904 vol $6.86 each	2,770,909
Filed 2017-07-19 Tx date 2017-04-17	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-437,437 -64,400 vol $6.79 each	2,706,509
Filed 2017-07-19 Tx date 2017-04-18	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,196,913.056 -176,320 vol $6.79 each	2,530,189
Filed 2017-07-19 Tx date 2017-04-20	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,874,735.98 -273,800 vol $6.85 each	2,256,389
Filed 2017-07-19 Tx date 2017-04-20	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,300,889.897 -186,430 vol $6.98 each	2,069,959
Filed 2017-07-19 Tx date 2017-04-25	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-15,267,810.5881 -2,069,959 vol $7.38 each	0
Filed 2017-07-19 Tx date 2017-05-04	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 59 - Exercise for cash	$-686,164.77 -96,507 vol $7.11 each	1,267,873
Filed 2017-07-19 Tx date 2017-05-05	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 59 - Exercise for cash	$-1,526,264.2116 -215,702 vol $7.08 each	1,052,171
Filed 2017-07-19 Tx date 2017-05-08	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 59 - Exercise for cash	$-1,284,574.748 -181,240 vol $7.09 each	870,931
Filed 2017-07-19 Tx date 2017-05-09	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 59 - Exercise for cash	$-995,809.5392 -140,168 vol $7.10 each	730,763
Filed 2017-07-19 Tx date 2017-05-10	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 59 - Exercise for cash	$-826,185.93 -115,188 vol $7.17 each	615,575
Filed 2017-07-19 Tx date 2017-05-10	$AUPH Aurinia Pharmaceuticals Inc.	venBio Global Strategic Fund, L.P. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 59 - Exercise for cash	-615,575 vol	0
Filed 2017-07-14 Tx date 2017-07-05	$AUPH Aurinia Pharmaceuticals Inc.	Eglite, Erik 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$2,268,000 +280,000 vol $8.10 each	280,000
Filed 2017-07-14 Tx date 2017-07-03	$AUPH Aurinia Pharmaceuticals Inc.	Eglite, Erik 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-07-07 Tx date 2017-07-05	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 54 - Exercise of warrants	$20,539 +7,415 vol $2.77 each	7,415
Filed 2017-07-07 Tx date 2017-07-05	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	$-20,539.55 -7,415 vol $2.77 each	0
Filed 2017-07-07 Tx date 2017-07-05	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-46,492.05 -7,415 vol $6.27 each	0
Filed 2017-07-06 Tx date 2017-06-21	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		7,400
Filed 2017-07-04 Tx date 2017-06-30	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-48,420 -6,000 vol $8.07 each	17,769
Filed 2017-07-04 Tx date 2017-06-30	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-24,800 -4,000 vol $6.20 each	23,769
Filed 2017-06-30 Tx date 2017-06-26	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-105,773.55 -16,399 vol $6.45 each	0
Filed 2017-06-30 Tx date 2017-06-21	$AUPH Aurinia Pharmaceuticals Inc.	ECONOMIDES, VASSILIKI NICHOLE (CELIA) 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report		150,000
Filed 2017-06-30 Tx date 2017-06-26	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-16,399 vol	248,601
Filed 2017-06-30 Tx date 2017-06-26	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-16,399 vol
Filed 2017-06-30 Tx date 2017-06-26	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$60,020 +16,399 vol $3.66 each	16,399
Filed 2017-06-30 Tx date 2017-06-26	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$59,200 +16,399 vol $3.61 each
Filed 2017-06-30 Tx date 2017-06-26	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-136,649.70 -21,186 vol $6.45 each	0
Filed 2017-06-28 Tx date 2017-06-23	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	50,000
Filed 2017-06-28 Tx date 2017-05-08	$AUPH Aurinia Pharmaceuticals Inc.	Milne, George M 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-06-27 Tx date 2017-06-26	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-39,540 -6,000 vol $6.59 each	31,769
Filed 2017-06-27 Tx date 2017-06-26	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-35,160 -4,000 vol $8.79 each	27,769
Filed 2017-06-27 Tx date 2017-06-23	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-20,000 vol	455,776
Filed 2017-06-27 Tx date 2017-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-43,400 -5,000 vol $8.68 each	32,769
Filed 2017-06-27 Tx date 2017-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-19,650 -3,000 vol $6.55 each	29,769
Filed 2017-06-27 Tx date 2017-06-23	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-26,240 -4,000 vol $6.56 each	17,769
Filed 2017-06-27 Tx date 2017-06-23	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-69,040 -8,000 vol $8.63 each	21,769
Filed 2017-06-27 Tx date 2017-06-23	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$70,000 +20,000 vol $3.50 each	37,769
Filed 2017-06-23 Tx date 2017-06-21	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-117,647.64 -13,200 vol $8.91 each	625,499
Filed 2017-06-23 Tx date 2017-06-21	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,015,363.7072 -117,188 vol $8.66 each	508,311
Filed 2017-06-23 Tx date 2017-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-283,012.605 -32,850 vol $8.62 each	475,461
Filed 2017-06-23 Tx date 2017-06-21	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,015,363.7072 -117,188 vol $8.66 each	508,311
Filed 2017-06-23 Tx date 2013-10-23	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-31,296,258 vol	638,699
Filed 2017-06-23 Tx date 2017-06-23	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-315,645.8844 -36,762 vol $8.59 each	438,699
Filed 2017-06-23 Tx date 2017-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-283,012.605 -32,850 vol $8.62 each	475,461
Filed 2017-06-23 Tx date 2017-06-21	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-117,647.64 -13,200 vol $8.91 each	625,499
Filed 2017-06-23 Tx date 2017-06-23	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-315,645.8844 -36,762 vol $8.59 each	438,699
Filed 2017-05-03 Tx date 2017-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$472,499 +50,000 vol $9.45 each	210,000
Filed 2017-05-01 Tx date 2017-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Ayers, Gregory Martin 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$189,000 +20,000 vol $9.45 each	50,000
Filed 2017-04-28 Tx date 2017-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Rovinski, Benjamin 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$189,000 +20,000 vol $9.45 each	70,000
Filed 2017-04-28 Tx date 2017-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Randall, Lorin Jeffry 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$189,000 +20,000 vol $9.45 each	50,000
Filed 2017-04-28 Tx date 2017-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$189,000 +20,000 vol $9.45 each	60,000
Filed 2017-04-28 Tx date 2017-04-26	$AUPH Aurinia Pharmaceuticals Inc.	Lee, Hyuek Joon 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$189,000 +20,000 vol $9.45 each	60,000
Filed 2017-03-22 Tx date 2017-03-20	$AUPH Aurinia Pharmaceuticals Inc.	ILJIN SNT Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 15 - Acquisition or disposition under a prospectus	$34,999,998 +5,185,185 vol $6.75 each	12,800,039
Filed 2017-03-22 Tx date 2017-03-20	$AUPH Aurinia Pharmaceuticals Inc.	ILJIN Lifescience Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	-4,586,606 vol	0
Filed 2017-03-22 Tx date 2017-03-20	$AUPH Aurinia Pharmaceuticals Inc.	ILJIN Lifescience Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 11 - Acquisition or disposition carried out privately	-145,533 vol	0
Filed 2017-03-22 Tx date 2017-03-20	$AUPH Aurinia Pharmaceuticals Inc.	ILJIN SNT Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	+4,586,606 vol	7,614,854
Filed 2017-03-22 Tx date 2017-03-20	$AUPH Aurinia Pharmaceuticals Inc.	ILJIN SNT Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 11 - Acquisition or disposition carried out privately	+145,533 vol	1,405,419
Filed 2017-03-02 Tx date 2017-02-16	$AUPH Aurinia Pharmaceuticals Inc.	Lee, Hyuek Joon 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$47,300 +10,000 vol $4.73 each	40,000
Filed 2017-03-02 Tx date 2017-02-16	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$47,300 +10,000 vol $4.73 each	40,000
Filed 2017-02-21 Tx date 2017-02-16	$AUPH Aurinia Pharmaceuticals Inc.	Rovinski, Benjamin 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$47,300 +10,000 vol $4.73 each	50,000
Filed 2017-02-19 Tx date 2017-02-16	$AUPH Aurinia Pharmaceuticals Inc.	Randall, Lorin Jeffry 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$47,300 +10,000 vol $4.73 each	30,000
Filed 2017-02-15 Tx date 2017-02-09	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 11 - Acquisition or disposition carried out privately	+65,000 vol
Filed 2017-02-15 Tx date 2017-02-14	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-3.75 -15 vol $0.25 each	160,000
Filed 2017-02-15 Tx date 2017-02-13	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-2.00 -10 vol $0.20 each	160,015
Filed 2017-02-15 Tx date 2017-02-09	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+65,000 vol	265,000
Filed 2017-02-14 Tx date 2017-02-09	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$639,920 +152,000 vol $4.21 each	339,439
Filed 2017-02-13 Tx date 2017-02-09	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$736,750 +175,000 vol $4.21 each	475,776
Filed 2017-02-13 Tx date 2017-02-09	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$378,900 +90,000 vol $4.21 each	277,439
Filed 2017-02-13 Tx date 2017-02-09	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$463,100 +110,000 vol $4.21 each	297,537
Filed 2017-02-13 Tx date 2017-02-09	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$4,420,500 +1,050,000 vol $4.21 each	1,270,000
Filed 2017-02-13 Tx date 2017-02-09	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 11 - Acquisition or disposition carried out privately	+65,000 vol	265,000
Filed 2017-02-10 Tx date 2017-02-09	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+55,000 vol	160,025
Filed 2017-01-27 Tx date 2017-01-24	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-8,835 -3,000 vol $2.94 each	6,237
Filed 2017-01-27 Tx date 2017-01-25	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$-5.00 -25 vol $0.20 each	105,025
Filed 2017-01-25 Tx date 2017-01-20	$AUPH Aurinia Pharmaceuticals Inc.	Randall, Lorin Jeffry 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+10,000 vol	20,000
Filed 2017-01-12 Tx date 2016-12-28	$AUPH Aurinia Pharmaceuticals Inc.	ILJIN SNT Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,999,999 +1,333,333 vol $2.25 each	3,028,248
Filed 2017-01-12 Tx date 2016-12-28	$AUPH Aurinia Pharmaceuticals Inc.	ILJIN SNT Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 10 - Acquisition or disposition in the public market	$1,499,998 +666,666 vol $2.25 each	1,259,886
Filed 2017-01-12 Tx date 2017-01-12	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 10 - Acquisition or disposition in the public market	$5.00 +50 vol $0.10 each	105,050
Filed 2017-01-06 Tx date 2017-01-05	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,186 +770 vol $2.84 each	770
Filed 2017-01-06 Tx date 2014-06-16	$AUPH Aurinia Pharmaceuticals Inc.	Robertson, Stephen P. 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-01-05 Tx date 2017-01-04	$AUPH Aurinia Pharmaceuticals Inc.	Rowland, Charles 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$141,186 +65,714 vol $2.15 each	334,431
Filed 2017-01-05 Tx date 2017-01-05	$AUPH Aurinia Pharmaceuticals Inc.	Rowland, Charles 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$932.45 +434 vol $2.15 each	334,865
Filed 2017-01-05 Tx date 2017-01-03	$AUPH Aurinia Pharmaceuticals Inc.	Rowland, Charles 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$72,213 +33,852 vol $2.13 each	268,717
Filed 2017-01-03 Tx date 2017-01-03	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,180 +2,000 vol $2.09 each	9,237
Filed 2017-01-03 Tx date 2016-11-16	$AUPH Aurinia Pharmaceuticals Inc.	Randall, Lorin Jeffry 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-01-03 Tx date 2016-12-14	$AUPH Aurinia Pharmaceuticals Inc.	Randall, Lorin Jeffry 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+10,000 vol	10,000
Filed 2016-10-07 Tx date 2016-09-20	$AUPH Aurinia Pharmaceuticals Inc.	ILJIN Lifescience Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 36 - Conversion or exchange	-333,333 vol	145,533
Filed 2016-10-07 Tx date 2016-09-20	$AUPH Aurinia Pharmaceuticals Inc.	ILJIN Lifescience Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 36 - Conversion or exchange	$833,332 +333,333 vol $2.50 each	4,586,606
Filed 2016-09-26 Tx date 2016-09-16	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 52 - Expiration of options	-1,000 vol	187,537
Filed 2016-09-01 Tx date 2016-08-30	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Options 52 - Expiration of options	-10,000 vol	300,776
Filed 2016-09-01 Tx date 2016-08-30	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 52 - Expiration of options	-4,000 vol	188,537
Filed 2016-08-11 Tx date 2016-08-03	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 52 - Expiration of options	-4,000 vol
Filed 2016-08-11 Tx date 2016-08-03	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 52 - Expiration of options	-4,000 vol
Filed 2016-08-11 Tx date 2016-08-03	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Options 52 - Expiration of options	-10,000 vol
Filed 2016-08-11 Tx date 2016-08-03	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Options 52 - Expiration of options	-10,000 vol
Filed 2016-08-09 Tx date 2016-08-03	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 52 - Expiration of options	-4,000 vol	188,537
Filed 2016-08-09 Tx date 2016-08-03	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Options 52 - Expiration of options	-10,000 vol	300,776
Filed 2016-07-28 Tx date 2016-07-21	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+40,000 vol	105,000
Filed 2016-07-28 Tx date 2016-07-22	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Triskel Health LLC (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-4,545 -1,500 vol $3.03 each	0
Filed 2016-06-28 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Cheoin Leisure Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-28 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Direct Ownership	Warrants 11 - Acquisition or disposition carried out privately	$205,401 +74,152 vol $2.77 each	163,041
Filed 2016-06-28 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Cheoin Leisure Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 16 - Acquisition or disposition under a prospectus exemption	$1,399,999 +593,220 vol $2.36 each	593,220
Filed 2016-06-28 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Cheoin Leisure Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-28 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Cheoin Leisure Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 16 - Acquisition or disposition under a prospectus exemption	$3,999,999 +1,694,915 vol $2.36 each	1,694,915
Filed 2016-06-27 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	$500,001 +211,865 vol $2.36 each	939,453
Filed 2016-06-24 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Rowland, Charles 4 - Director of Issuer Direct Ownership	Warrants 11 - Acquisition or disposition carried out privately	+74,153 vol	74,153
Filed 2016-06-24 Tx date 2014-07-29	$AUPH Aurinia Pharmaceuticals Inc.	Rowland, Charles 4 - Director of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-24 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Rowland, Charles 4 - Director of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	$500,001 +211,865 vol $2.36 each	234,865
Filed 2016-06-24 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Warrants 11 - Acquisition or disposition carried out privately	+7,415 vol	7,415
Filed 2016-06-24 Tx date 2016-04-29	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-24 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	$49,998 +21,186 vol $2.36 each	21,186
Filed 2016-06-24 Tx date 2016-04-29	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-23 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Warrants 11 - Acquisition or disposition carried out privately	+1,483 vol	1,483
Filed 2016-06-23 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Warrants 11 - Acquisition or disposition carried out privately	+1,483 vol	1,483
Filed 2016-06-23 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	$9,999 +4,237 vol $2.36 each	54,572
Filed 2016-06-23 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Warrants 11 - Acquisition or disposition carried out privately	+1,483 vol	1,483
Filed 2016-06-23 Tx date 2016-01-04	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-23 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	$9,999 +4,237 vol $2.36 each	7,237
Filed 2016-06-23 Tx date 2016-06-22	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	$9,999 +4,237 vol $2.36 each	37,769
Filed 2016-06-18 Tx date 2016-06-17	$AUPH Aurinia Pharmaceuticals Inc.	Rowland, Charles 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$3,200,000 +1,000,000 vol $3.20 each	1,040,000
Filed 2016-05-05 Tx date 2016-04-29	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-05-05 Tx date 2016-05-02	$AUPH Aurinia Pharmaceuticals Inc.	Dickerson, Bradley 5 - Senior Officer of Issuer Direct Ownership	Options 11 - Acquisition or disposition carried out privately	+200,000 vol	200,000
Filed 2016-04-01 Tx date 2016-03-31	$AUPH Aurinia Pharmaceuticals Inc.	Zaruby, Stephen Walter 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$150,400 +40,000 vol $3.76 each	1,230,717
Filed 2016-04-01 Tx date 2016-03-30	$AUPH Aurinia Pharmaceuticals Inc.	Bourgeault, Dennis 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$156,400 +40,000 vol $3.91 each	310,776
Filed 2016-04-01 Tx date 2016-03-30	$AUPH Aurinia Pharmaceuticals Inc.	Huizinga, Robert 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$156,400 +40,000 vol $3.91 each	192,537
Filed 2016-03-31 Tx date 2016-03-30	$AUPH Aurinia Pharmaceuticals Inc.	Martin, Michael Robert 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$156,400 +40,000 vol $3.91 each	187,439
Filed 2016-03-31 Tx date 2016-03-30	$AUPH Aurinia Pharmaceuticals Inc.	Solomons, Neil 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$156,400 +40,000 vol $3.91 each	187,439
Filed 2016-03-28 Tx date 2016-03-23	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Triskel Health LLC (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-4,500 -1,500 vol $3.00 each	1,500
Filed 2016-03-28 Tx date 2016-03-23	$AUPH Aurinia Pharmaceuticals Inc.	Lee, Hyuek Joon 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$39,600 +10,000 vol $3.96 each	30,000
Filed 2016-03-28 Tx date 2016-03-23	$AUPH Aurinia Pharmaceuticals Inc.	Jayne, David Roland Walker 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$39,600 +10,000 vol $3.96 each	30,000
Filed 2016-03-27 Tx date 2016-03-23	$AUPH Aurinia Pharmaceuticals Inc.	Ayers, Gregory Martin 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$39,600 +10,000 vol $3.96 each	30,000
Filed 2016-03-25 Tx date 2016-03-23	$AUPH Aurinia Pharmaceuticals Inc.	Glickman, Richard 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$39,600 +10,000 vol $3.96 each	220,000
Filed 2016-03-24 Tx date 2016-03-23	$AUPH Aurinia Pharmaceuticals Inc.	Rovinski, Benjamin 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$39,600 +10,000 vol $3.96 each	40,000
Filed 2016-03-24 Tx date 2016-03-23	$AUPH Aurinia Pharmaceuticals Inc.	Rowland, Charles 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$39,600 +10,000 vol $3.96 each	40,000
Filed 2016-01-21 Tx date 2016-01-14	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,900 +1,000 vol $2.90 each	3,000
Filed 2016-01-21 Tx date 2016-01-15	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Triskel Health LLC (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$1,686 +1,000 vol $1.69 each	3,000
Filed 2016-01-12 Tx date 2016-01-04	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Holder: Triskel Health LLC (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report		2,000
Filed 2016-01-12 Tx date 2016-01-04	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		2,000
Filed 2016-01-12 Tx date 2016-01-04	$AUPH Aurinia Pharmaceuticals Inc.	Gluck, Rashieda 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report		65,000